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ABSTRACT OF DISSERTATION

EXPLORE THE RELATIONSHIP AMONG LUNG CANCER STIGMA, SOCIAL
SUPPORT, AND PSYCHOSOCIAL DISTRESS
There is longstanding causal relationship between cigarette smoking and lung
cancer. Smoke-free policies and anti-smoking campaigns have been linked to the decline
in smoking acceptance and contribute to the unintended consequence of stigmatizing
smokers. Lung cancer is viewed as a self-inflicted disease and patients’ feel judged in a
manner different from other cancers affecting social interactions between family, friends,
and healthcare professionals. Lung cancer stigma contributes to depression, anxiety, poor
self-esteem, guilt, shame, blame, threatens a person’s social identity, and limits social
support that deeply affects patients and their support persons.
This dissertation contains a review of the literature related to smoking and stigma,
an evaluation of the psychometric properties of an investigator-developed instrument,
“Lung Cancer Stigma Scale” (LuCaSS) and the main findings from a cross-sectional
observational study of 104 lung cancer patients assessing factors associated with lung
cancer stigma. The Model of Stigma Induced Identity Threat provides the framework to
examine stigma and the relationship between social constraints, self-esteem, and smoking
and to test whether social support mediates the relationship between stigma, and
depression/anxiety.
The LuCaSS was a reliable and valid instrument measuring lung cancer stigma
(alpha = 0.89). The principle components analysis determined three subscales measuring
internalized stigma: social rejections/judgment, blame/guilt, and shame. Social
constraints, self-esteem, smoking each significantly contributed to the prediction of
stigma controlling for SES. Lung cancer patients with greater social constraints and lower
self-esteem and who were smokers scored higher on stigma. Social support was a
mediator for the relationship between stigma and depression but not for anxiety. The
findings are consistent with Stigma Induced Identity Threat Model. A stigmatized
identity can lead to stress-related health outcomes such as depression.
A lung cancer diagnosis has numerous negative psychosocial effects on patients.
Integrating stigma tools (i.e. LuCaSS) in practice settings may assist with determining
potential stigma related distress among lung cancer patients. Emphasizing the need for
social support and implementing more advocacy efforts may also help minimize the

effects of stigma and depression. Future studies are necessary to further examine the role
of social support in minimizing stigma and psychosocial distress.
KEYWORDS: Stigma, smoking, lung cancer, social constraints, self-esteem, social
support.
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CHAPTER ONE
Introduction
The causal relationship between cigarette smoking and lung cancer has been
known for more than 50 years (USDHEW, 1964; US Department of Health & Human
Services, 2014). Lung cancer is the leading cause of cancer death in men and women in
the United States (American Cancer Society, 2012). More people die from lung cancer
than from breast, colorectal, prostate and pancreatic cancer combined and more women
die from lung cancer than breast cancer. In excess of 160,000 deaths were attributed to
lung cancer in 2012, with approximately 90% related to cigarette smoking in men and
almost 80% in women (American Cancer Society, 2012).
To address the tobacco related disease epidemic, public health initiatives have
focused on restricting tobacco use through public policy (e.g., smoke-free policies) and
anti-smoking campaigns for more than 30 years (Fichtenberg & Glantz, 2002). These
initiatives have been designed to protect non-smokers from the hazards of secondhand
smoke and de-normalize smoking behavior (Poutvaara & Siemers, 2008). As a result,
these initiatives have reshaped societal thinking about tobacco use and unintentionally
placed blame on smokers for the diseases it causes.
In most areas of the United States, smoking is viewed as an unacceptable behavior
(Bayer, 2008; Gilpin, Lee, & Pierce, 2004; Alamar & Glantz, 2006; Stuber, et al., 2008).
The unintended consequences of effective antismoking campaigns and smoke-free
policies have led to the stigmatization, ostracism, and discrimination of smokers
(Falomir-Pichastor, et al., 2009). Smokers are often stigmatized and set apart from nonsmoking society members leading to stereotyping, judgment and discrimination. Lung
cancer is viewed as a self-inflicted disease regardless of person’s smoking status,
perpetuating the belief that those with the disease do not deserve empathy or support
(Struber, Galea, & Link, 2008; Chapple et al., 2004). The repercussions may be
membership in a devalued social group increasing a person’s exposure to stressful
identity threatening situations (Major and O’Brien, 2005). Identity threat endangers the
aspect of one’s self or self-esteem, producing physical and psychosocial challenges that
compromise a person’s quality of life and promote social constraints that may lead to

1

depression and anxiety (Else-Quest, et al., 2009; Carlson et al., 2005; Chapple et al.,
2004).
The Model of Stigma Induced Identity Threat (Major and O’Brien, 2005)
provides the framework for this dissertation. Key concepts of the model are tested
including personal characteristics (socioeconomic status, self-esteem, social constraints
smoking) and the effects of lung cancer stigma on psychosocial distress (i.e., anxiety and
depression) and the role of social support as a mediator of those relationships. The model
posits that being stigmatized produces a threat to the aspect of the self that is derived
from membership in a devalued social group or category (lung cancer patient) and
assumes that possessing a devalued social identity increases one’s exposure to potentially
stressful (identity threatening) situations. A threat to one’s identity can result in
discrimination and lead to a number of psychosocial distress and negative health
outcomes such as depression/anxiety and limited social support (Chapple, et al., 2004;
Major and O’Brien, 2005; Cataldo, et al., 2011; Brown-Johnson, et al., 2014;). Stigmainduced identity threat results when an individual appraises demands as potentially
harmful to their social identity and the demand exceeds the resources to cope (Major and
O’Brien, 2005).
This dissertation consists of five chapters. Chapter 2 is an integrative review of
the literature related to smoking stigma and how it pertains to lung cancer and mental
health outcomes. Stigma is an attribute or behavior that conveys a devalued social
identity separate from an accepted normal one (Goffman, 1963). Public health initiatives
aimed at protecting non-smokers and de-normalizing smoking behavior have had
unintended consequences contributing to the stigma that smokers experience (Struber,
Galea, & Link, 2008; Chapple et al., 2004). Stigma in healthcare is considered a powerful
force in the lives of individuals from marginalized groups such as those with HIV/AIDS,
mental health, cancer, and sexually transmitted infections (Phelan, et al., 2002).
Stigma affects the psychological wellbeing of those who experience it. Having a
stigmatized social identity contributes to anxiety, depression, guilt, shame, blame, and
poor quality of life (Chapple, et al., 2004; Cataldo, et al., 2012; Carlson, et al., 2005;
Brown-Johnson, et al., 2014; Morse, et al., 2008). Stigma functions by signaling disgust
in those perceived to be “normal” and shame in those who are stigmatized. Experiencing
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stigma triggers fear of rejection, limits seeking help and social support, (Corner, et al.,
2005) and is associated with poor health outcomes and decreased survival (Struber,
Galea, & Link, 2008; Chapple et al., 2004; Cataldo, et al., 2011).
Chapter 3 describes the development and psychometric testing of the investigatordeveloped Lung Cancer Stigma Scale (LuCaSS). Items from validated HIV stigma
measures were modified for the LuCaSS and framed in the context of lung cancer
(Berger, et al., 2001; Fife & Wright, 2000; and Elmet, 2005; Sowell, et al., 1997). The
primary aims of Chapter 3 are to describe the internal consistency of the LuCaSS and
evaluate the construct validity of the instrument through principle components analysis.
Testing instruments designed to assess a patient’s perceived stigma and its effects may
enhance knowledge, empathy and understanding to improve comprehensive,
nonjudgmental care and develop future prevention strategies.
Chapter 4 describes the results of a cross-sectional observational study of 104
lung cancer patients to assess factors (i.e., social support, social constraints and selfesteem) associated with stigma and how these variables are related to anxiety and
depression. Testing constructs of the Model of Stigma-Induced Identity Threat, the study
has three main objectives: 1) explore the relationships among social constraints, selfesteem, smoking, and stigma; 2) determine the relationships between stigma and anxiety
and depression, controlling for smoking and socioeconomic status (SES); and 3)
determine if social support mediates the relationships between stigma and depression and
stigma and anxiety. It was hypothesized that there would be a relationship between selfesteem, social constraints, smoking, and lung cancer stigma. Hypothesis 2 was that social
support would mediate the relationships between stigma, depression, and anxiety.
Chapter 5 provides a summary of the findings from the dissertation. In addition,
implications for practice and suggestions for future research, prevention, and advocacy
are discussed. Also, the ethical considerations associated with deploying stigma as a
justified means of social control to discourage unhealthy behaviors are discussed. Smokefree policies, anti-smoking campaigns and associated media messages are beneficial to
curbing smoking prevalence and de-normalizing smoking behavior. However, more
research is needed to understand how stigma impacts initiation and help seeking
behaviors as well as how social movements may demand action to reduce stigma (Brown,
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1995). Social movements led and championed by professional associations and advocacy
organizations may provide effective population-based social support to minimize stigma
experienced by lung cancer patients, caregivers, and providers.

Copyright © Lisa Maggio 2015
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CHAPTER TWO
Stigma, Smoking, and Lung Cancer: A Systematic Review of the Literature
Abstract
Aims: This systematic literature review explored the: a) concepts of health-related
stigma; b) effects of stigma on the lack of lung cancer research funding and advocacy; c)
relationship between smoking stigma and lung cancer; and d) overview of the Model of
Stigma-Induced Identity Threat and the psychosocial effects of being stigmatized.
Background: Stigma is an attribute that conveys a devalued “social identity” outside of
an accepted “normal” one. The unintended consequences of smoke-free policies and antismoking campaigns have contributed to the view that smoking is an unacceptable
behavior and that lung cancer is a “self-inflicted” disease as a result of smoking.
Data Source: Literature search included the following key words: stigma, smoking, and
lung cancer. Lung cancer funding and advocacy were also reviewed with regard to their
relationship with smoking and lung cancer stigma.
Review Methods: Inclusion criteria included peer-reviewed research manuscripts and
systematic reviews of research published between January 1998 and December 2014.
Nineteen manuscripts met the inclusion criteria for smoking, stigma and/or lung cancer.
Determining eligibility for manuscript selection was achieved through skimming the
abstracts and titles.
Results: Stigma is most likely to exist among people with diseases linked to controllable
causes (smoking) prompting less empathy and more blame. As a result, lung cancer
patients are seen as responsible or “deserving” of their disease regardless of their
smoking status. Prevention and cessation efforts, provided through smoke-free policies,
are essential for lung cancer prevention and treatment. However, the stigma experienced
by lung cancer patients negatively impacts psychological adjustments and interpersonal
communication. The Model of Stigma-Induced Identity Threat explains how lung cancer
stigma “threatens a person’s identity” and is associated with greater distress, poorer
psychological adjustment and limited use of support services.
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Lung cancer stigma as “identity threat” has influenced the lag in appropriate
research funding and advocacy affecting any advances toward better prevention,
treatment and survival.
Conclusion: Stigma is a social process resulting in discrediting or devaluation of a
person or group and exists as a means of social control and regulating behavior. Smoking
represents the primary risk factor for lung cancer and is the connection to the growing
negative public perceptions that unintentionally result in stigma against lung cancer
patients. As a result, lung cancer patients experience higher levels of cancer-related
stigma than patients with other cancers.
Key words: smoking, stigma, and lung cancer.

Introduction
As one of the most common smoking-related malignancies, lung cancer is the
leading cause of cancer death in men and women in the United States (American Cancer
Society, 2012). More people die from lung cancer than from breast, colorectal, prostate
and pancreatic cancer combined and more women die from lung cancer than breast
cancer. In excess of 160,000 deaths were attributed to lung cancer in 2012, with
approximately 90% related to cigarette smoking in men and almost 80% in women
(American Cancer Society, 2012). Lung cancer is among the most preventable diseases
(CDC, 2010).
The hazards of smoking have been well established for more than 50 years (US
Department of Health & Human Services, 2014) and are known to contribute to an
epidemic of smoking-related diseases and millions of deaths worldwide. Although active
smoking is responsible for the majority of new lung cancer cases and deaths, secondhand
smoke (SHS) exposure is also a cause of lung cancer. More than 7,300 nonsmokers die
from lung cancer acquired from exposure to SHS each year (U.S. Department of Health
and Human Services, 2014). Tobacco use presents just one of the known causes of lung
cancer. There are other carcinogens present in the workplace and home that may increase
the risk of developing lung cancer such as radon and asbestos exposure. It is estimated
more than 20,000 radon-induced lung cancers occur each year in the U.S. (United States
6

Environmental Protection Agency, 2012). Radon, an odorless, colorless gas that comes
from rocks and soil, can get trapped in buildings and, if undetected, increases the risk of
developing lung disease and cancer (EPA, 2012). In addition, high levels of radon
combined with smoking produces a synergistic effect adding to the increased risk of
developing lung cancer. Examples of other substances that may be found in some
workplaces and increase lung cancer risk include arsenic, some forms of silica, and
chromium (USDHHS, 2004).
Other variables known to increase the chances of developing lung cancer include
gender differences and molecular alterations between never smokers and smokers,
indicating other potential causes of the disease (Sun, Schiller, & Gazdar, 2007). Studies
have shown that the “Y” chromosome, thought to contribute to tumor containment, is
deleted in the blood of men who smoke making men more susceptible to lung cancer.
Smoking and age were associated with a loss of “Y” chromosome in the blood,
increasing the risk for lung cancer in men (Dumanski, Rasi, Lonn, et al., 2014). In
women, estrogen or its metabolites may be a factor that increases lung cancer risk.
Smoking alters estrogen receptors expressed on lung cancer cells, increasing cell
proliferation of mutated cells and estrogen’s role in both premalignant and malignant
disease progression (Sun et al. 2007; Couraud, et al. 2012; Taioli &Wynder, 1994;
Pesatori, Carungno, et al. 2013). EGFR (epidermal growth factor receptor) and EML4ALK (echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase)
are specific mutations found mostly in non-smokers with lung cancer (Rudin, et al. 2009;
Wing-SzeWong, D., et al. 2009).
Lung cancer has one of the lowest survival outcomes of any cancer (Howlander,
et al., 2014). The overall five-year survival rate for lung cancer has not changed in more
than 40 years (13% in 1970 vs. 17.4% in 2014). The five-year survival rate for lung
cancer when confined to a primary site, diagnosed and treated, is approximately 53% but
declines significantly to 3.9% when the cancer has metastasized. Unfortunately, only
approximately 16% of lung cancer cases are diagnosed in an early-localized stage
(Howlander, et al., 2014). One factor that contributes to the dismal survival rates is late
diagnosis of the disease when the tumor is inoperable or has metastasized. Early
diagnosis greatly improves the chances of long-term survival (ACS, 2012).
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The purpose of this systematic review was to explore the: a) concepts of healthrelated stigma; b) effects of stigma on the lack of lung cancer research funding and
advocacy; c) relationship between smoking stigma and lung cancer; and d) constructs of
the Model of Stigma-Induced Identity Threat and the psychosocial effects of being
stigmatized.
Methods
A systematic literature search was conducted via numerous library databases
(PsycINFO, WebSPIRS, OVIDSP, PubMed, CINAHL) using the key words of stigma,
smoking, and lung cancer (neoplasms). Lung cancer funding and advocacy were also
reviewed with regard to their relationship to stigma. Inclusion criteria included
conceptual definitions of stigma associated with lung cancer and smoking. To be
included, research studies and systematic reviews were published in peer-reviewed
journals between January 1998 and December 2014 and limited to the English language.
Studies that were not specific to health-related stigma were excluded from the search, as
were those pertaining to treatment, diagnostic, or prevention studies.
The initial search method produced 111 publications and abstracts. Forty-seven
studies were regarded as “supportive literature” related to the concept of stigma. Nineteen
publications met the inclusion criteria for smoking, stigma and/or lung cancer (see Table
2.1). Determining eligibility of studies was achieved through skimming the abstracts and
titles.
Concepts of Health-related Stigma
Stigma is defined as an attribute, behavior, or reputation that is socially
discrediting in a specific way that may cause an individual to be mentally classified by
others in an undesirable, rejected stereotype, rather than in an accepted, normal one
(Goffman, 1963). Since the original stigma work (Goffman, 1963), the definition of
stigma has varied considerably to include a characteristic of an individual contrary to the
norm of the social unit. The meaning of “norm” includes a common belief that a person
ought to behave in a certain way at a certain time (Stafford & Scott, 1986).
More recently, the words “stigma” and “stigmatization” refer to an “invisible
sign” of disapproval permitting “insiders” to draw a line around the “outsiders” in order
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to distinguish group inclusion limits. The distinction permits “insiders to know who is
‘in’ and who is ‘out’ and allows the group to maintain its commonality by demonstrating
what happens to those who deviate from the accepted norm of conduct (Falk, 2001).
Stigma and the act of stigmatization are an issue of disempowerment and social injustice
(Scheyett, 2005).
Link and Phelan (2001) described stigma as “when elements of labeling,
stereotyping, separation, status loss, and discrimination occur together in a power
situation that allows them” (p.377). Stigma exists when the following interrelated
components converge. The first component is that people distinguish and label human
differences. Second, dominate cultural beliefs associate labeled persons to undesirable
characteristics and negative stereotypes. Third, distinct categories label persons in order
to achieve separation of “us” from “them.” The fourth component occurs when labeled
persons experience a loss in status and discrimination leading to unequal outcomes.
Lastly, stigmatization is solely dependent on access to social, economic, and political
power permitting the identification of differentness, creation of stereotypes, division, loss
of status, and discrimination (Link & Phelan, 2001).
According to these five components of stigma, the nature of labeling a person
provides the impetus to separate us from them. The person is thought to be the thing that
they are labeled. For example, because smoking causes lung cancer, these patients may
be labeled as “smokers” regardless of their actual smoking status. Another example,
people who have seizures may be labeled as epileptics instead of a person with epilepsy.
Labeling helps us understand the social processes involved in how society allows one
group’s views to dominate what becomes a real and important consequence for another
group.
Stigma is further described by sociologist Gerhard Falk (2001) and is categorized
into two types: 1) existential stigma, and 2) achieved stigma. Existential stigma is derived
from a condition that occurs without a known cause or from which there was little
control. Achieved stigma is earned based on a person’s conduct and/or because they
contributed heavily to the condition or behavior (Falk, 2001). Existential stigma often
accompanies a cancer diagnosis, because there is a lack of understanding of the cause and
it is often viewed as a death sentence (Lapore & Revenson, 2007; Chapple et. al., 2004).
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Patients often experience vulnerability, lack of control over their health, and a need to
protect others from embarrassment (Rosman, 2004; Frank, 1991). Although the patient
often asks, “what did I do to cause this?” the reality is that some malignancies are genetic
occurrences or the cause is unknown and not controllable. Cigarette smoking is a known
cause of lung cancer, as noted in the 1964 United States Surgeon General’s Report on
Smoking and Lung Cancer –a clear indication of the causal relationship between cigarette
smoking and lung cancer (U.S. Department of Health, Education, and Welfare, 1964). A
lung cancer diagnosis can result in achieved stigma because the disease is considered to
be “self-inflicted” (Chappel et.al. 2004; Spader, 2008; Gylyn & Youssef, 2010).
Diseases associated with the highest degree of stigma share common attributes:
(1) a person with the disease is seen as responsible for having the illness; (2) the disease
is progressive and incurable; (3) the disease is not well understood among the public; and
(4) the symptoms cannot be concealed (Goffman, 1963, Falk, 2001). People often try to
conceal stigmatized health conditions or avoid situations that may reveal these
conditions, which often lead to delays in seeking health care and information (Link et. al.
1992, Tod, Craven, Allmark, 2007), unnecessary suffering, lost productivity, and suboptimal use of health care resources (Berger, Wagner, & Baker, 2005). Researchers
conclude that the process of stigmatizing someone is not possible unless they lack social,
economic or political power in comparison to the person being stigmatized (Link &
Phelan, 2001). The powerful have greater access to resources and influence. Stigma
exists when labeling, negatively stereotyping, discriminating against, exclusion, and low
status co-occur in power situations that allow them to occur (Link & Phelan, 2001).
Stigma differs from prejudice, stereotype, and discrimination, although they are part of
the stigma experience. Prejudice is an attitude or negative judgment toward a group and
its members. Stereotype is a belief about a group, and discrimination is an unjustified
negative or harmful behavior toward members of a group (Heatherton, et al., 2003).
In summary, stigma is the expression of negative attitudes about someone or
something thought to be socially unacceptable. Stigma can be a result of misinformation
leading to fear and misunderstanding. As the dangers of smoking became more apparent,
well-intentioned efforts to restrict smoking and exposure to secondhand smoke may have
caused a negative reaction to smokers. Because smoking represents the primary risk for
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lung cancer, the disease is still seen by many as self-inflicted. Stigma ascribed to
controllable factors (achieved stigma) such as smoking elicits a greater negative reaction
than stigma ascribed to uncontrollable factors (existential stigma) such as breast cancer
(Weiner, Perry, & Magnusson, 1988). Stigma may also threaten a person’s identity,
social life, and economic opportunities and deeply affect families and support persons
(Fife et al. 2000). Stigma associated with disease is dependent on the perception of
patient responsibility for the disease and whether the disease leads to a serious disability,
disfigurement, lack of control, or disruption of social interactions (Goffman, 1963; Falk,
2001; Link, Cullen, Mirotznik, & Struening, 1992; Berger, Wagner, & Baker, 2005).
Stigma and Lung Cancer Research Funding and Advocacy
Although lung cancer contributes to one of the highest cancer mortality rates, it
receives the least amount of federal government research funding compared to breast,
colon and prostate cancer. Total research spending dollars per death in fiscal year 2010
was $28,660 for breast cancer; $13,697 for prostate cancer; $6,872 for colon cancer, and
$1,386 for lung cancer (National Cancer Institute, 2012; Centers for Disease Control &
Prevention, 2010). The limited research funding for lung cancer may result from the
public view that lung cancer is a punishment for smoking resulting in stigmatization of
lung cancer patients (Chapple, et at. 2004; Knapp-Oliver, 2012; Oliver and Moyer 2012).
The inequity in research funding contributes to the lack of progress and improvement in
early detection, screening, treatment, advocacy and awareness (Gulyn and Youssef,
2010). The history of stigma research provides the context for understanding the
processes related to the disparities noted in lung cancer and the expected outcomes of
being stigmatized.
Relationship between Smoking Stigma and Lung Cancer Stigma
Because of the longstanding causal relationship between cigarette smoking
(USDHEW, 1964) and lung cancer, smoke-free policies were introduced not only to
protect non-smokers from exposure to secondhand smoke but also to aid public health
strategies aimed at de-normalizing smoking and encourage society to view tobacco use as
undesirable antisocial behavior (Bayer, 2008; Gilpin, Lee, & Pierce, 2004; Americans for
Non-Smokers’ Rights, 2003; Alamar & Glantz, 2006). Although smoke-free policies
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have contributed to the decline in tobacco use in the U.S. (Almar & Glantz, 2006), they
also have added to the stigmatization and prejudice toward smokers (Stuber, Meyer, &
Link, 2008; Chapple et al., 2004).
Denormalizing tobacco use by changing the social norms became the basis for the
tobacco control movement (Bell et al., 2010) including strategies to limit where smoking
is permitted, how tobacco products are sold, the dangers of first and secondhand smoke
through media campaigns and exposing the tobacco industry’s manipulative tactics to
promote their products (Bell et al., 2010).
The role of social norms, defined as rules or standards that are understood by
members of a group, are in place to guide and/or constrain social behaviors with or
without law enforcement. Goffman (1963) argued that stigma is a common feature of any
society because nonconformity of social norms is unavoidable and persistent. Therefore,
stigma is a consequence for failing to comply with social norms for the purpose of
making the nonconformist less deviant so they can rejoin the group (Stuber and Galea,
2009). For example, when family and friends express disapproval of smoking, these
social norms contribute to smoker-related stigma (Stuber, et al., 2008).
The rise of smoke-free policies in the United States not only reminds us of the
health consequences of secondhand smoke exposure but also that the societal attitude has
changed and public smoking is no longer considered acceptable (Stuber et al. 2009). The
unintended consequences of effective antismoking campaigns and smoke-free policies
have led to stigmatization, ostracism, and discrimination endured by smokers (FalomirPichastor, et al., 2009). In addition, healthcare providers and epidemiologists may
describe smokers as defiant, weak, making poor choices, or lacking willpower (Street,
2004). In reality, many smokers attempt to quit numerous times only to relapse due to
challenges of nicotine addiction and withdrawal (Fiore et.al. 2008). A person who
smokes may have the desire and willingness to address their smoking addiction and
comply with the new social norms. However, the addictive nature of nicotine and the lack
of support for or access to nicotine dependence treatment create a dilemma for the
smoker.
Smoke-free policies contribute to stigma in two ways: 1) social policy contributes
via structural forms of discrimination (private and governmental policies); and 2)
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symbolic messages or moral condemnation (Schneider & Ingram, 1993). Structural
policies perpetuate discrimination that restricts opportunities of “marginalized” groups,
whether intentional or not, and range from companies refusing to hire smokers to
employers having to pay more for the health insurance of their employees who smoke.
By way of structural policies, the process to separate or lower placement or status may
potentiate smoking-related stigma (Pample, 2006; Stuber, and Galea, 2009). Symbolic
messages or moral condemnation are designed to punish or segregate a particular group
from another, thereby increasing stigmatization. Smoke-free laws, designed to protect
non-smokers, arguably were imposed on the act of smoking and not on the smoker.
However, these policies that force smokers to huddle outside or segregate them to
designated smoking rooms at airports, may create the perception of an undesirable
person. Many smokers view the media as promoters of stigma because television
advertisement aimed at the young to deter smoking illustrate a dreadful and terrifying
death, exacerbating fear and anxiety (Chapple et al., 2004). The awareness of smoke-free
policies by smokers and former smokers contribute to the likelihood of experiencing
smoker-related stigma (Stuber et al., 2008).
In summary, as the dangers of tobacco use have become known, well-intentioned
efforts to restrict it have often led to negative reactions to smokers. Because a history of
smoking is the primary cause of lung cancer, the disease is seen as self-inflicted, leading
to a higher incidence of stigma for this type of cancer. Stigma exists among people who
develop lung cancer, regardless of their smoking status (current, former, or never
smokers) (Chapple, et. al., 2004; Sun, Schiller, & Gazdar, (2007).
Model of Stigma-Induced Identity Threat
Overview. The Model of Stigma-Induced Identity Threat (Major, O’Brien, 2005)
integrates identity threat models of stigma (Crocker, Major, Steele, 1998) with
transactional models of stress and coping (Lazarus, Folkman, Smith 1984). An identity
threat is a threat to the aspect of self that is derived from membership in a devalued social
group or category (Tajelf and Turner, 1986). The model assumes that possessing a
consensually devalued social identity (stigma) increases one’s exposure to potentially
stressful (identity threatening) situations. The model posits that situational cues,
collective representations of one’s stigma status, personal beliefs and motives shape
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people’s appraisals of the significance of those situations for wellbeing (Major, O’Brien,
2005). Identity threat appraisals result when an individual appraises the demands imposed
by being stigmatized as potentially harmful to their social identity and those stressors
exceed the individual’s coping mechanisms. Events are appraised for significance of
wellbeing and outcomes of this appraisal process directs affective, cognitive, behavioral
and physiological responses to that event. The response is then involuntary (nonvolitional responses) and/or voluntary (volitional responses) leading to specific outcomes
(See Figure 1.1).
Mechanisms of Stigmatization. There are four mechanisms that directly affect
the psychological wellbeing of those who are socially stigmatized: (1) Negative treatment
or direct discrimination; (2) expectancy confirmation or self-fulfilling prophecy; (3)
automatic stereotype activation behavior; and (4) stigma induced identity threat.
Negative treatment or direct discrimination limits access to certain life domains
that affect a person’s social status, psychological wellbeing and physical health. For
example, healthcare systems establish tobacco-free campus policies that clearly designate
the boundaries where smokers are not permitted to smoke. Those who violate the policy
face corrective action or reprimands. Also, in accordance with hospital credentialing,
healthcare providers assess the smoking status of every patient upon admission. Smokefree policies and smoking assessment policies signal that the smoking behavior is
unacceptable and can create a separation between “us” and “them” (Stuber, et al., 2008).
The accumulation of institutional policies and practices may work to further disadvantage
those who are stigmatized even when individual prejudice or discrimination are absent.
Expectancy confirmation or self-fulfilling prophecy occurs when individuals
perceive negative stereotypes that influence certain behaviors toward a stigmatized
person in ways that directly affect their thoughts, feelings, and behaviors (Darley and
Fazio, 1980). The stigmatized person may then confirm the initial inaccurate
expectations, stereotypes, or prejudicial attitudes. For example, patients with symptoms
of lung cancer may delay seeking treatment as a coping mechanism to avoid being judged
(Corner, et al. 2006). Contributing to this mechanism of stigmatization, when healthcare
providers perceive lung cancer to be self-inflicted and hopeless, they are less likely to
offer aggressive treatment options than they would to other cancer patients, especially if
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the patient continues to smoke (Levealahti, et al. 2007). Important to note is that
perceptions of situations do not always correspond to objective events. Some individuals
who are targets of objective discrimination fail to realize it and others believe they are
victims of discrimination even when they are not (Major et al, 2002b).
Automatic stereotype activation behavior creates an involuntary reaction in the
absence of discriminatory behavior on the part of others. These automatic responses are
referred to as “the power of an idea (over the body)” associated with linkages in memory
between stereotypes and the behaviors they imply. These memory linkages lead to
initiation of the stereotype and assimilate the stereotype behavior. Lung cancer patients
who are aware of the stereotype (blame and guilt) may “automatically” behave differently
(withdrawn, avoidance) regardless of whether there are observable discriminatory actions
(Major and O’Brien, 2005). For example, a never smoking female lung cancer patient
about to receive chemotherapy may tell people who ask when she loses her hair, that she
has breast cancer because she doesn’t want to be judged.
Stigma as Identity Threat
Stigma-induced identity threat is the model that explains how experiencing a
stigmatized identity can lead to stress and stress-related health outcomes through the
coping process (Major and O’Brien, 2005). A person’s identity may be derived from their
race, age, ethnicity, occupation, heritage etc. Social identity provides a sense of
membership or connection with other people (Tajfel and Turner, 2004), and is a valuable
key contributor to self-esteem and self-concept. People are motivated to protect their
identities from anything that may threaten or harm their self-esteem by demeaning or
devaluing their identity (Steel et al., 2002). Possessing a consensually devalued social
identity (stigma) increases the potential exposure to stressful or identity threatening
situations. Stigma-induced identity threat can occur as a result of discrimination or other
identity related threatening situations leading to psychological, physiological, and social
outcomes such as depression/anxiety, considerable stress, and limited social support
(Major and O’Brien, 2005; Steele, Spencer, & Aronson, 2002). Stigma related identity
threat occurs as a result of three processes that shape a persons’ evaluation of being
stigmatized and the significance of situations: collective stereotypes/representations,
situational cues, and individual personal characteristics (Major & O’Brien, 2005) .
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Collective Stereotypes/Representations are based on prior experiences and
exposure to the dominant culture (i.e., non-smokers, health care providers, anti-tobacco
messages). Stigmatized members develop shared understandings of the dominant view of
their stigmatized status in society (Crocker 1999, 1998; Steele, 1997). Collective
representations include awareness that individuals are devalued in the eyes of others,
knowledge of the dominant cultural stereotypes of their stigmatized identity, and
recognition that they are victims of discrimination (Crocker et al. 1998).
Collective representations influence how the stigmatized perceive and appraise
stigma-relevant situations. They can affect the behavior of the stigmatized in the absence
of obvious forms of discriminatory behavior on the part of others, and even when no
other person is immediately present. For example, anti-smoking media messages don’t
directly tell a smoker their behavior is unacceptable. However, they create images that
may induce harm to the person or others (Crocker et al. 1998).
Situational cues differ in their social identity threat potential or the extent to
which they signal one is at risk of being devalued, negatively stereotyped, or
discriminated against because of ones’ social identity (Steele, et al., 2002). For example,
when a stigmatized lung cancer patient experiences a threatening situation, such as being
asked if smoking was the cause of their disease, they may immediately feel blame
regardless of their smoking history or they may feel incorrectly judged because they
never smoked. There could also have been exposure to situational cues such as certain
media messages or images that reinforce negative stereotypes of one’s group (Davies et
al, 2002).
Personal Characteristics influence how situations are perceived and appraised.
There are a number of personal characteristics that contribute to the appraisals such as
socioeconomic factors, self-esteem, experiencing social constraints, and smoking history.
The personal characteristic appraisals are explained through sensitivity to stigma, group
identification, and goals and motives.
Stigma sensitivity involves expecting to be treated on the basis of their group
membership (i.e., smoker) rather than their personal identity. Because a person belongs
to a certain group they become more sensitive to rejection and they often expect to be
treated differently. For example, smoking is no longer viewed by society as an acceptable
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behavior. People with lung cancer who continue to smoke may “expect to be treated”
with less respect or feel disdain based solely on their group membership of being a
smoker. The disdain experienced by smokers may directly affect their self-esteem, selfconcept and lead to greater social constraints from family and friends. People who score
higher on a measure of stigma consciousness or sensitivity are more likely to perceive
themselves as targets of discrimination at both a personal and group level; they also tend
to lean more toward words that threaten their social identity (Pinel, 1999).
Group identification refers to individuals who view their stigmatized social
identity as an essential part of their self-identity. These individuals are more likely to see
themselves as objects of personal and group discrimination, especially when the prejudice
cues they experience are ambiguous. For example, smoke-free workplace policies require
workers who smoke to go outside. Smokers are expected to “huddle” outside in the cold
and are singled out by their co-workers as less motivated, unfairly using the smoke break
as a means to avoid work, and lacking will-power or discipline for continuing to smoke
(Stuber, et al., 2008).
Goals and motives also shape how individuals perceive and appraise situations.
There are two motives that are emphasized in the stigma literature: 1) the motive to
protect or enhance self-esteem; and 2) belief that the system is just and they are fairly
treated (Crocker, et al. 1998). For example, not every lung cancer patient believes they
are to blame for their disease and will reject any notion that they had control over the
cause or any attempt to stigmatize them. This belief has been reported mostly in former
or never smokers and those with higher self-esteem, social support and social influence
(Major, et al., 2002b).
Identity Threat Appraisal is assessment of the demands, the relevance of the
situation, and resources to cope with those demands. Threat is the perception that a
person is at risk for a negative or possibly harmful event (Major and O’Brien, 2005). For
example, being stigmatized may lead to feelings of rejection, judgment, and limited
resources or social support (Chapple et al., 2004; Cataldo et al., 2010). Stigma-induced
identity threat results when a person appraises the demands imposed by a ‘stigmarelevant’ stressor as potentially harmful to the persons’ social identity and the resources
to cope are surpassed (Major and O’Brien, 2005).
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The appraisal process can occur through automatic, nonverbal, instantaneous and
the unconscious. Appraisals can also result from feelings that are processed from shared
observations of dominant views (situational cues). The coping mechanisms for identity
threatening situations are through involuntary and voluntary responses (Major and
O’Brien, 2005).
Involuntary responses are coping mechanisms to address identity threat and
include non-verbal anxiety and physiological/emotional and cognitive responses such as
elevated blood pressure, increased vigilance and working memory load; and behavioral
responses that may affect academic achievement and health. These responses do no serve
to regulate or modify stressful experiences (Major and O’Brien, 2005). Voluntary
responses also influence our ability to cope by way of conscious “volitional” efforts to
control emotion, cognition, behavior, physiology and environmental responses to events
or circumstances viewed as stressful. Seeking and receiving social support is a voluntary
response and a coping mechanism (Major and O’Brien, 2005).
Individuals cope with stigma-induced identity threat in several ways: engaging or
blaming the discrimination they feel on others versus blaming themselves; disengaging or
withdrawing their efforts from the situations where they are negatively stereotyped or
fear being the target of discrimination. Stigmatized groups may also cope with identity
threat by aligning more closely with their group (Allport, 1954). The advantage of
belonging to a group is that they can provide those who are stigmatized with emotional,
informational and influential support, and social validation for their perceptions and a
sense of belonging. Branscombe et al. (1999) found a positive correlation between group
identification and self-esteem, resulting in favorable outcomes.
Outcomes of stigmatization involve coping strategies and trade-offs. Strategies
necessary to achieve specific outcomes (e.g., preserving self-esteem, limiting anxiety and
depression) may interfere with achieving other outcomes, such as minimizing prejudice
and discrimination. (Major & O’Brien, 2005). In order to improve the predicament of the
stigmatized, we need to seek a better understanding of the factors that contribute to an
individual’s vulnerability as well as their resilience to stigma so that effective coping
strategies are identified for dealing with identity-threatening situations.
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In summary, the Model of Stigma-Induced Identity Threat examines how
mechanisms of stigma can directly affect the psychological wellbeing of those who are
socially stigmatized. Identity threat poses a risk to a person’s self that is derived from
membership in a devalued social group. This can increase a person’s exposure to
potentially stressful or identity threatening situations. Experiencing a stigmatized identity
can lead to stress-related health outcomes such as depression/anxiety. Individuals who
experience stigma may appraise threatening situations through collective representations,
situational cues, and personal characteristics. Coping mechanisms for identity-threatening
situations may occur through involuntary or voluntary responses and the outcomes may
vary based on one’s coping abilities, their vulnerability and resilience to being
stigmatized.
Lung Cancer Stigma and the Effects on Psychological Well-being
Stigma contributes to depression, anxiety, guilt, shame, and blame (Chapple et al.,
2004; Cataldo et al., 2012; Brown-Johnson, et al. 2014; Morse, et al. 2008). In a
prospective study, researchers evaluated guilt, shame, and depression among non-small
cell lung cancer (NSCLC) patients compared to patients’ with breast and prostate cancer.
Women with NSCLC were found to have increased levels of guilt, shame, and depression
compared to breast cancer patients. They were also more likely to experience depression
than their male counterparts. Guilt, shame, and depression may hamper patients’ ability
to advocate for themselves and may affect treatment outcomes. (Schmidt, Else-Quest,
Hammes, Eickhoff, Hyde, & Schiller, 2006). In addition, psychological stress responses
can lead to impaired social responses and interactions between the stigmatized and their
health care providers (Stuber, et al., 2008). Further, depression, anxiety, (Gonzales and
Jacobsen, 2010) and feelings of blame can negatively affect the physician-patient
relationship (Chapple et al., 2004; Street, 2004). Prejudice and discrimination contribute
to health disparities jeopardizing prevention and treatment efforts (USDHHS, 2002). To
avoid judgment, lung cancer patients may avoid discussions that draw attention to their
unhealthy behaviors. Stigma can produce individuals who are feared, avoided, regarded
as deviant, and even blamed for their choices that caused their affliction (Guttman &
Salmon, 2004). Lung cancer patients often feel judged in a manner that is different from
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any other cancer with a less apparent cause, affecting social interactions among family,
friends, and medical professionals (Chapple, et al. 2004, Sun, Schiller, & Gazdar, 2007).
Stigma associated with lung cancer also contributes to concealment of illness after
diagnosis and threatens necessary coping mechanisms that lead to decreased adherence to
treatment, greater disability and reduced quality of life (Carter-Harris, Herman, et al.
2014; Conlon et al. 2010). For example, researchers found that healthcare system
mistrust, stigma and smoking status influenced delay in seeking medical treatment.
Delaying and concealing illness was related to the expected blame they would receive for
their illness regardless of their smoking status. Without psychosocial supports, lung
cancer patients feel shunned by society, their families, and abandoned by the oncology
community (Corner et al. 2005; Sun, Schiller, & Gazdar, 2007).
Stigma has been shown to threaten a person’s identity, social life, and economic
opportunities and deeply effect families and support persons (Fife, et al. 2000). Lung
cancer stigma and prejudice have been linked to serious health consequences including
constricting social networks and compromised quality of life (Chapple, et al. 2004; Zoe
& Raleigh, 2010).
A cancer survivor’s ability to cope with their diagnosis involves the “mutual
influence” of their social network (significant others, family, friends) as a means of
cognitively and behaviorally addressing the stressors of the disease (Lepore & Revenson,
2007). Individuals who experience stigma may feel constrained and avoid discussing
their cancer in an attempt to buffer against intrusive thoughts that are upsetting in order to
limit the amount of negative social interactions. Avoidance may hinder the necessary
coping processes by limiting contemplation of the experience. The negative effect of a
person’s intrusive thoughts on mental health is also exaggerated by social constraints. In
contrast to social constraints, social support can strengthen mental health through
environments essential for cognitive processing of the traumatic events and by utilizing
verbal disclosure of thoughts and feelings (Lepore and Helgeson, 1998).
Social constraints can affect how patients communicate with and confide in their
health care providers, loved ones, and advocacy organizations. Levelalhti et al. (2007)
conducted a descriptive study exploring the views of patients with inoperable lung
cancer, who have survived the first year post diagnosis, in regard to how they frame and
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conceptualize the onset of their illness (Levelalhti, Tishelman, & Ohlen, 2007). Patients
experienced a wide array of bodily experiences that may not immediately lead to a
diagnosis. Some reported symptoms related to other disorders such as heart disease or
systemic complaints thought to be symptoms or indicators of a serious problem (malaise
& poor condition). Other symptoms were less frequent but triggered an immediate
reaction such as debilitating cough and vomiting (Levelalhti, Tishelman, & Ohlen, 2007).
A lack of a strong communal voice between lung cancer patients and advocacy
organizations was also reported. The lack of patient advocacy for lung cancer patients
differs drastically from other cancer groups, such as breast cancer patients, who have
actively influenced public and professional awareness (Else-Quest et al., 2009; Zoe and
Raleigh, 2010; Siminoff, et al., 2010). Media coverage for lung cancer is focused on the
connection with smoking, which study participants emphasized as connections to their
past rather than their current situation. Media coverage associating stigma and blame
portrayed the smoker as lax in responsibility to practice self-care and quit smoking
(Levelalhti, Tishelman, & Ohlen, 2007; Street, 2004).
Summary
Researchers have studied the effects of stigma on mental health and relationship
lifestyles (HIV/AIDS, smoking) for more than 20 years and conclude that the prejudice
against members of stigmatized or oppressed groups causes undue emotional, social, and
physical stressors (Bayer, 2008; Bell, et. al., 2010; Struber, Meyer, Link, 2008).
Researchers have also identified the importance of understanding the linkages between
stigma, prejudice, discrimination and health, essential in the development of effective
public health initiatives (Struber, Meyer, Link, 2008). The public attitude and perceptions
toward lung cancer patients show a lack of concern, caring and sensitivity needed by not
only health care professionals, but also community members, especially when
communicating with patients about their illness that many consider “self-inflicted”
(Chapple et al., 2004).
Discussion
There are a number of indicators that determine the social discovery of a disease.
According to Brown (1995), the following four indicators need to be present: 1) lung
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cancer patients and their loved ones need to initiate seeking help; 2) there needs to be a
social movement demanding action for lung cancer patients’; 3) health care professionals
dealing with the disease must be champions for lung cancer; and 4) having strong
advocacy organizations is imperative (Brown, 1995). To date, lung cancer has missed
these key indicators and only recently has stigma been addressed in the media, among
healthcare providers, and patient advocacy groups.
Additional studies are needed to further assess attitudes and perceptions of lung
cancer patients, their families, community members, media, and policymakers.
Assessing the level of stigma related to smoking and lung cancer among the general
public is important to better understand barriers to funding research, advocacy,
prevention and treatment efforts. There may be benefits in examining smoke-free policy
and anti-tobacco messaging so that they don’t alienate tobacco users from non-tobacco
users. The message from “Free to Breathe,” a lung cancer advocacy organization is “if
you have lungs you can get lung cancer” (Freetobreathe.org). The benefits of assessing
this population may lead to development and testing of population-based interventions to
reduce societal stigma and enhance advocacy, awareness, and social support. Perhaps we
have neglected the true source of suffering? If the aim is to minimize “the stress,”
psychological harm, and increase the self-esteem of the victim, we may have overlooked
that the perpetrator (society) is the problem and not the victim. We seem to have chosen
to focus on the problems of the oppressed rather than on the problem of the oppressor
(Meyer, 2003).
Conclusion
For more than 160,000 Americans, a lung cancer diagnosis can mean a death
sentence. Assessment of the effects of stigma associated with smoking and lung cancer
may provide insight into the threat to social support, advocacy efforts and adequate
research funding. Addressing the stigma felt by so many lung cancer patients may also
pave the way toward the development of population-based interventions that limit the
effects of stigma and judgment threatening the psychological wellbeing of lung cancer
patients and their families.
Copyright © Lisa Maggio 2015
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Table 2.1 Stigma, Smoking and Lung Cancer Summary of the Literature
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Author(s) Citation

Purpose/Design

Sample/Methods

Findings/Conclusion

1. Alamar, B., & Glantz, S. (2006).
Effect of increased social
unacceptability of cigarette smoking
on reduction in cigarette consumption.
American Journal of Public Health,
96,1359-1363.

Cigarette consumption
affected by taxes and social
factors. Impact measured with
social unacceptability index
regarding permissible
locations for smoking.

Data on cigarette prices
and consumption from tax
burden on tobacco, survey
data on individual attitudes
toward smoking policy.

Policies that increase the social
unacceptability of smoking and taxes
that increase cigarette prices have
similar effects in terms of reducing
cigarette consumption. Social
unacceptability index and price effects
are independent.

2. Bayer, R. (2008). Stigma and the
ethics of public health: not can we but
should we. Social Science & Medicine,
67, 463-472.

Provides a systematic review
of stigma, the targets, and the
effects on public health, the
moral concerns.

Systematic review of
stigma and public health
literature. HIV/AID and
smoking stigma, ethics

It is the responsibility of public health
officials to counteract stigma if they
are to fulfill their mission to protect
community health. Mobilization of
stigma may effectively reduce the
prevalence of behaviors linked to
disease and death and human rights
issues.

3. Brown-Johnson, C., Brodsky, J.,
Cataldo, J. (2014). Lung cancer
stigma, anxiety, depression, & quality
of life. Journal of Psychosocial
Oncology, 32, 59-73.

Investigated lung cancer
stigma, anxiety, depression
and QOL & validated variable
similarities between ever and
never smokers. Descriptive
cross-sectional study,
correlational design.

Evaluating relationships
among anxiety,
depression, LCS, & QOL.
Online questionnaire
N=149.

LCS is positively associated with
anxiety and depression and negatively
associated with QOL. Regardless of
smoking status, lung cancer patients
experience LCS.
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4. Carter-Harris, L., Hermann, C.,
Schreiber, J., Weaver, M., Rawl, S.
(2014). Lung cancer stigma predicts
timing of medical-help-seeking
behavior. Oncology Nursing Forum,
41, 3, E203-E208.

Examines relationships among
demographic variables,
healthcare system distrust,
lung cancer stigma, smoking
status, & timing of medical
health-seeking behavior in
individuals with symptoms
suggestive of lung cancer.

Descriptive crosssectional, correlational
study, self-report survey
controlling for SES and
social desirability.

Lung cancer stigma was independently
associated with timing of medical
help-seeking behavior in patients with
lung cancer serving as barrier to
prompt medical help seeking behavior.
Findings suggest that stigma influences
medical-help seeking behavior and is a
barrier to prompt medical care.

5. Cataldo, J., Jahan, T., Pongquan, V.
(2012) Lung cancer stigma,
depression, and quality of life among
ever and never smokers. European
Journal of Oncology Nursing, 16(3):
264-9.

Compare levels of lung cancer
stigma & relationship between
lung cancer stigma,
depression, & QOL among
ever & never smokers.

Exploratory descriptive
study of 192 patients
diagnoses with lung
cancer. Self-report online
survey.

Positive relationship between stigma &
depression. Strong inverse
relationship with QOL. Controlling for
age, gender, smoking & depression,
lung cancer stigma contributes to
variance in QOL. Perceived stigma can
lead to negative outcomes including
increased levels of depression and
decreased QOL.

6. Chapple, A., Ziebland, S., &
McPherson, A. (June, 2004). Stigma,
Shame, and Blame experienced by
patients with lung cancer: Qualitative
study. British Medical Journal,
10(7C), 1-5. Retrieved April, 19, 2008,

Explores perceptions and
experience of stigma among
lung cancer patients.

Qualitative Study to draw
on narrative interviews
with patients with 45 lung
cancer.

Patients with lung cancer report
stigmatization with far reaching
consequences. Efforts to help people to
quit smoking are important, but
clinical and educational interventions
should be presented with care so as not
to add to the stigma experienced by
patients with lung cancer and other
smoking related diseases.
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7. Conlon, A., Gilbert, D., Jones, B.,
Aldredge, P. (2010). Stacked stigma:
oncology social workers’ perceptions
of the lung cancer experience. Journal
of Psychosocial Oncology, 28 (1), 98115.

Explores stigma in lung cancer
experience.

Qualitative interviews
with 19 oncology social
workers who provide care
to people diagnosed with
lung cancer and their
family members.

Content analysis of interviews: stacked
stigma (multidimensional) exists with
respect to cigarette smoking. Poor
prognosis and disparity in advocacy
efforts emerged as stigmatizing events
linked to smoking stigma, particularly
in arenas of support groups, patient
matching programs & availability of
resources.

8. Corner, J. Hopkinson, J. Roffe, L.
(2006). Experience of health changes
and reasons for delay in seeing care: a
UK study of the months prior to the
diagnosis of lung cancer. Social
Science & Medicine, 62, 1381-1391.

Determining events leading to
delay in diagnosing cancer.
Data recalled from events prior
to early & late stage lung
cancer diagnosis are explored.

Descriptive study, quota
sample, interview study
N=22, recently dx early &
late stage lung cancer.

Individuals, regardless of disease stage
or social background failed to
recognize symptoms (serious)
experienced over many months prior to
eventual diagnosis. Symptoms were
attributed to everyday causes. Some
were more reluctant to seek help
because unclear in distinguishing
normal from abnormal or feeling
unworthy of medical care.

9. Else-Quest, N.,LoConte, N.,
Schiller, J, Hyde, J. (2009). Perceived
stigma, self-blame, and adjustment
among lung, breast, and prostate
cancer patients. Psychology & Health;
24(8): 949-64.

Descriptive study examines
the links among
stigmatization, self-blame and
adjustment in advanced stage
lung, breast and prostate
cancer patients.

172 participants, 96 stage
IV lung cancer, 30 breast
and 46 prostate cancer
patients. Mailed
questionnaire assessing
stigma, self-blame, selfesteem, anxiety, anger,
depressed affect and
causal attributions for
cancer.

Lung cancer patients attributing their
disease to internal causes reported
higher self-blame, poorer self-esteem,
and higher depressed affect, anxiety
and anger than patients with breast or
prostate cancer. Lung cancer patients
who felt guilt, shame, or blame for
their disease had worse mental health
outcomes.

Table 1.1 (Continued)
Descriptive study Identifies
the association between
perceived stigma related to
lung cancer diagnosis and
depressive symptomatology.

N=95 stage 2-4 LC
receiving RX in outpatient
center. Modified labeling
theory.

Positive association b/t perceived
stigma & depressive symptomatology,
r=0.46, p<0.001. Avoidant coping,
poorer social support, dysfunctional
attitude.

11. Gulyn, L. M., & Youssef, F.
(2010). Attribution of blame for breast
and lung cancers in women. Journal of
Psychosocial Oncology, 28(3), 291301.

Descriptive study reviewing
social perception of blame
involved in breast and lung
cancer.

Research review of social
perception of serious
illness & causal
explanation.

Causal explanation fall into 2
categories: 1) patients behavior; 2)
factors outside the patient control.
Additional questions concerning
coping, stigma, & responses of health
care providers and research
communities suggested for future
study.

12. Knapp-Oliver, S. (2012). Causal
attributions predict willingness to
support the allocation of funding to
lung cancer treatment programs.
Journal of Applied Social Psychology,
Vol. 42 (10), pp. 2368-2385.

Descriptive study examines
whether causal attributions for
the contractions of lung cancer
predict the stigmatization of
individuals with the disease by
investigating willingness to
support the allocation of funds
to hypothetical lung cancer
treatment programs.

462 participants
randomized to receive
lung or breast
questionnaire to determine
preferences using
hypothetical situations.

Participants who made causal
attributions preferred to support
allocations to fund programs that value
the lives of breast cancer patients
rather than lung cancer patients.
Implications for understanding the
influence of causal attributions on the
stigmatization of lung cancer.

13. Morse, D., Edwardsen, E., &
Gordon, H. (2008). Missed
opportunities for interval empathy in
lung cancer communication. Archives
of Internal Medicine, 168(17), 18531858.

Descriptive study evaluates
empathetic opportunities
physician responses.

137 VA lung cancer
patients interviewed. A
qualitative analysis.

MD provided little emotional support
of often shifting to biomedical
questions& statements. When empathy
was provided 50% occurred in last 1/3
of encounters. Empathy is important in
patient/md communication.

26

10. Gonzalez, B. and Jacobsen, P.
(2010). Depression in lung cancer
patients: the role of perceived stigma.
Psycho-Oncology. 10, 102-18.

Table 1.1 (Continued)
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14. Schmidt, N., Else-Quest, N.,
Hammes, L., Eickhoff, J., Hyde, J.,
Schiller, J. (2006). Evauations of guilt,
shame and depression in non-small cell
lung cancer (NSCLC) relative to breast
and prostate cancer. Journal of
Clinical Oncology, 2006 ASCO
Annual Meeting Proceedings Part 1,
Vol. 24, No.185 (June 20 Supplement)
7158.

Prospective quantitative study
evaluating guilt, shame and
depression in NSCLC relative
to breast and prostate cancer.

Completion of 3 surveys
over 6 months.
Standardized tests of
shame, guilt and
depression.

NSCLC is associated with increased
levels of guilt and shame leading to
depression, relative to breast and
prostate cancer. This disparity is
particularly striking among women
with NSCLC. Guilt, shame, and
depression may hamper a patients’
ability to advocate for themselves and
may affect treatment outcomes.

15. Siminoff, L., Wilson-Genderson,
M., Baker, S. (2010). Depressive
symptoms in lung cancer patients and
their family caregivers and the
influence of family environment.
Psycho-Oncology, 19; 1285-1293.

Investigates depressive
symptomatology in lung
cancer patients and their
identified caregivers.

Semi-structured interviews
and measures of family
environment, depressive
symptomatology, and the
extent to which the
caregiver blamed the
cancer on the patient.

The family environment and blaming
the patient during times of illness can
affect both patient and caregiver
depression. Younger caregivers,
spouse caregivers, and caregivers who
blamed the patient for the cancer had
higher depressive symptom scores.

16. Stuber, J., Meyer, I., Link, B.
(2008). Stigma, prejudice,
discrimination and health.

Descriptive study examines
stigma formation in the
context of the tobacco
epidemic & examined the role
of attribution, fear, tobacco
control policies, power and
social norms in the formation
of smoker-related stigma.

Population –based sample
of 816 current and former
smokers in NYC.
Telephone questionnaire
items measuring stigmarelated to being a smoker.
12-item scale to assess
devaluation &
discrimination.

Perceptions of individual’s attributions
for smoking behaviors and fear about
the health consequences of secondhand
smoke are important influences on
smoker-related stigma. White, more
educated respondents perceive more
smoker-related stigma than less
education. Black & Latino perceive
less smoker-related stigma than white
persons. Social norms & family/friends
expressed disapproval of smoking
contributing to smoking-related
stigma.

Social Science & Medicine, 67, 351357.

Table 1.1 (Continued)
Identifies factors influencing
delay in reporting symptoms
of lung cancer.

Qualitative study, N=18
conducted from July 2005
to May 2006. Purposive
sample of people
diagnosed with lung
cancer in community &
hospital settings.

Barriers to symptoms reporting
included experience, lack of
knowledge fear, blame stigma related
to smoking. Cultural factors,
nonstandard healthcare utilization &
underlying stoical attitudes. Family
support positive influence in
overcoming delay.

18. Tod, A. M., & Joanne, R. (2010).
Overcoming delay in the diagnosis of
lung cancer: a qualitative study.
Nursing Standard, 24(31), 35-43.

Explores factors influencing
the delay in reporting
symptoms of lung cancer;
develops early reporting tool
to prompt report of symptoms.

Qualitative, N=16
healthcare professional
(HCP), survivors,
community members to
discuss content. 6 focus
groups with 39 HCP &
members of the public to
assist with development of
screening tool.

Poor knowledge of lung cancer
symptoms. Tendency to attribute other
meanings to the symptoms, selfmanagement of cough & fear of HCP
attitudes, i.e., blame and stigma
associated with smoking.

19. Raleigh, Z. (2010). A
biopsychosocial perspective on the
experience of lung cancer. Journal of
Psychosocial Oncology, 28 (1), 166125.

Examines the effects of an
individual’s smoking status
(current, former, never) on the
biological, social, and
psychological aspects of lung
cancer.

A review of literature
related to biopsychological
perspective including
social aspects and
psychological aspects.

Social stigma of lung cancer affects all
patients with lung cancer irrespective
of smoking status; the psychological
and biological consequences of the
disease vary with smoking status.
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17. Tod, A. M., Craven, J., & Allmark,
P. (2007). Diagnostic delay in lung
cancer: a qualitative study. Journal of
Advanced Nursing, 61(3), 336-343.

Figure 1.1 An Identity-Threat Model of Stigma in Lung Cancer
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CHAPTER THREE
Lung Cancer Stigma Scale (LuCaSS):
Measuring Perceived Stigma in People with Lung Cancer
Abstract
Purpose/Objectives: Describe the development of an investigator-developed instrument,
“Lung Cancer Stigma Scale” (LuCaSS) and evaluate its psychometric properties by: 1)
describing the internal consistency of the LuCaSS; and 2) assessing the construct validity
of the instrument through principle components analysis (PCA).
Design: Psychometric analysis of cross-sectional descriptive data set.
Sample: 104 patients diagnosed with lung cancer.
Methods: Cronbach’s alpha coefficients to assess internal consistency and Principle
Components Analysis (PCA) and to assess dimensionality and construct validity of the
15-item LuCaSS.
Findings: The LuCaSS was a reliable and valid instrument measuring lung cancer stigma
(alpha = 0.89). The principle components analysis determined three subscales measuring
internalized stigma: social rejections/judgment, blame/guilt, and shame.
Conclusions: Lung cancer patients are at high risk for psychological distress. Feelings of
rejection/judgment, blame/guilt and shame can manifest as a result of feeling stigmatized.
Testing instruments that assess stigma assist in understanding the salient constructs
associated with stigma and research tools needed to further the study of and test
interventions to minimize stigma experienced by lung cancer patients.
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Introduction
Lung cancer is the most common smoking-related malignancy and the leading
cause of cancer death in both men and women (United States Cancer Statistics, 2015).
Lung cancer poses many challenges to those afflicted because of high mortality rates,
(Howlander et al., 2014), psychological stressors (Gonzalez and Jacobsen, 2010; Cataldo
et al., 2010; Carlson, et al. 2005), and societal stigma (Chapple, et al. 2004; Cataldo et al.
2011). These challenges can weaken a person’s essential beliefs and expectations about
themselves and their illness, their relationships, and their future (Lepore & Revenson,
2007).
The public often holds misperceptions about lung cancer and smoking. Some
believe lung cancer is justified as they think only smokers get lung cancer; the disease is
self-inflicted; and they deserve it. As a result, lung cancer patients may suffer from
societal stigma and its consequences (Couranud, et al., 2012; LoConte, et al., 2008;
Chappel, et al., 2004).
Stigma is considered a powerful force in the lives of individuals believed to be
marginalized such as HIV/AIDS, mental health, cancer, and sexually transmitted
infections (Link and Phelan, 2001). Testing instruments designed to assess a patient’s
perceived stigma and the effects on their psychological well being may be advantageous
to enhancing our knowledge, empathy and understanding so we can improve our ability
to provide comprehensive, nonjudgmental care. It may also provide opportunities for
health care providers to advocate for these stigmatized populations, promote earlier
diagnosis, and minimize the adverse effects of feeling stigmatized.
The purpose of this study was to describe the development of an investigatordeveloped instrument, “Lung Cancer Stigma Scale” (LuCaSS) and evaluate its
psychometric properties by: 1) describing the internal consistency of the LuCaSS; and 2)
assessing the construct validity of the instrument through principle components analysis
(PCA).
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Background
Smoking, Lung Cancer and Stigma
There has been a longstanding causal relationship between cigarette smoking and
lung cancer (USDHEW, 1964). In recent years, there has been an increase in the social
unacceptability of smoking in the United States linked to smoke-free policies and
changes in social norms (Bayer, 2008; Gilpin, Lee, & Pierce, 2004; Alamar & Glantz,
2006; Stuber 2008; Fichtenberg & Glantz, 2002). These policies were introduced not only
to protect non-smokers from exposure to secondhand smoke but also to aid public health
strategies designed to de-normalize smoking and encourage society to view tobacco use
as an undesirable and antisocial behavior (Bayer, 2008; Gilpin, Lee, & Pierce, 2004;
Americans for Non-Smokers’ Rights, 2003; Alamar & Glantz, 2006). De-normalizing
tobacco use became the basis for the tobacco control movement (Bell et al., 2010)
including strategies to limit where smoking is permitted, how tobacco products are sold,
the dangers of first- and secondhand smoke through media campaigns, and exposing the
tobacco industry’s manipulative tactics used to promote their products (Bell et al., 2010).
The meaning of “norm” implies the common belief that a person ought to behave in a
certain way at a certain time (Stafford & Scott, 1986).
Although smoke-free policies have contributed to the decline in tobacco use in the
U.S. (Almar & Glantz, 2006), they also have contributed to the stigmatization and
prejudice toward smokers (Struber, Galea, & Link, 2008; Chapple et al., 2004). The
stigmatization of smokers and the strong relationship between smoking and lung cancer
may promote the stigma felt by both smokers and those diagnosed with lung cancer
(Bayer, 2008).
A lung cancer diagnosis creates additional challenges for patients and families
due to the societal perception that lung cancer is a smoker’s disease (Chapple, et al.,
2004; LoConte, et al., 2008) and that people who smoke willfully bring the disease on
themselves (Struber, et al., 2008). This perception can lead to a number of emotions
including a sense of guilt, shame, anger, blame and remorse (Chapple, et al., 2004;
Carmack, et al., 2008). As a result, people with lung cancer may experience greater
fears, lower self-esteem, emotional distress, and feelings of isolation, anxiety, and
depression (Gonzalez and Jacobsen, 2010; Cataldo, et al., 2011; Johnson, et al., 2014;
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Siminoff, et al., 2010). People diagnosed with lung cancer often experience negative
reactions from others such as criticism from family and societal blame. They often endure
feelings of guilt, and the emotions may become so stressful that they often delay or
decide not to seek appropriate screening and treatment (Tod, et al., 2010; Corner, et al.,
2005).
Stigma Research and Repercussions of Stigma
Stigma is defined as an attribute, behavior, or reputation that is socially
discrediting in a specific way that may cause an individual to be mentally classified or
labeled by others in an undesirable, rejected stereotype, rather than in an accepted,
normal one (Goffman, 1963). The person who experiences stigma is thought to be the
thing they are labeled. For example, lung cancer is associated with smoking, so people
diagnosed with lung cancer are often considered by society as “smokers”, regardless of
their smoking status.
Stigmatization is an issue of disempowerment and social injustice (Scheyett,
2005). Stigma associated with disease may be linked to the perception that the patient is
responsible for the disease and whether it leads to serious disability, disfigurement, lack
of control, or disruption of social interactions (Goffman, 1963; Falk, 2001; Link,
Struening, et.al. 2001; Berger, Wagner, Baker, 2005).
Lung cancer carries with it greater social stressors and societal stigma than other
cancers or other chronic diseases (Chapple, 2004; Conlon, 2010, Cataldo, 2011). The
public perception is that the disease is mostly preventable or associated with controllable
factors. Controllable factors create strong negative reactions (Weiner, Perry, Magnusson,
1988) affecting social interactions among all lung cancer patients regardless of their
smoking status (Raleigh, 2010).
Perceived stigma contributes to greater depressive symptomatology (Gonzales,
2010), feelings of shame for having caused the disease or guilt for not having prevented it
(Chapple, Ziebland, & McPherson, 2004), and feelings of blame that can negatively
affect psychosocial support between patient and physician and/or patient and family
(Chapple, et al., 2004). Limited psychosocial supports leave patients feeling ostracized by
the public, abandoned by the oncology community (Sun, Schiller, Gazdar, 2007), and
contribute to a lack of empathy for the patient (Morse, Edwardsen, Gordon, 2008). Lung
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cancer patients often feel judged in a manner that is different than other cancers with a
less apparent cause. This feeling of being judged can affect social interactions among
family, friends, and medical professionals (Chapple, et al. 2004, Sun, Schiller, Gazdar,
2007).
Stigma associated with lung cancer also contributes to concealment of illness after
diagnosis and threatens necessary coping mechanisms that may lead to decreased
adherence to treatment, greater disability and reduced quality of life (Chapple et al.,
2004; Morse, et al. 2008; Lobchuk, et al. 2008). Judgment, feeling ostracized, blame, and
guilt contribute to lack of treatment by more than half of all people with advanced lung
cancer, far more than for any other type of cancer (Small, et al., 2012; Earle, et al., 2002;
Ramsey, et al., 2004).
Methods
Development of the Lung Cancer Stigma Scale (LuCaSS)
When the Lung Cancer Stigma Scale (LuCaSS) was initially developed, there
were no other measures of lung cancer stigma. Much of the groundwork for measuring
stigma originated from HIV research: The HIV Stigma Scale (Berger, et. al. 2001; Social
Impact Scale (Fife & Wright, 2000), and HIV Stigma Scale (Emlet, 2005; Sowell et al.,
1997). These instruments have been consistently used and are considered to be the most
reliable and valid instruments for measuring HIV related stigma (Bunn, Solomon, Miller,
Forehand, 2007). Each of the three instruments was chosen because they evaluated a
diverse population (i.e., elderly, gender-specific, ethnic and cultural differences) and one
evaluated stigma in HIV patients compared to cancer patients (Fife & Wright, 2000).
Although the main focus of the survey questions has been to examine perceptions of
stigma related to HIV/AIDS, they have been adapted to examine the perception of stigma
in other health conditions (Else-Quest, et al., 2009). Table 3.1 provides a summary of the
three instruments used to develop the LuCaSS. Below is a brief summary of each of the
three existing instruments that were adapted to form items for the LuCaSS.
Berger’s HIV Stigma Scale. Berger and colleagues (2001) developed an
instrument to measure perceived stigma experienced by people with HIV based on the
stigma literature and psychological aspects of having HIV. The Model of Perceived
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Stigma in people with HIV was developed and the final instrument yielded 40-items on a
4-point Likert scale (strongly disagree, disagree, agree, and strongly agree). A high score
indicated stronger agreement with the item. The reading level was below sixth grade
(Berger, et. al., 2001). Examples include: “I work hard to keep my HIV a secret; I feel
guilty because I have HIV.” The Cronbach’s alpha for this scale was .96. Five of the 40
items representing rejection, judgment, and guilt dimensions were adapted for the
LuCaSS based on feedback from an expert panel (see below). Examples of the items
adapted from the Berger instrument and the dimension it reflects: “I have been hurt by
how people reacted to learning I have lung cancer (rejection);” “I feel guilty because I
have lung cancer (guilt).”
Social Impact Scale. Fife & Wright (2000) developed the “Social Impact Scale,”
grounded in the Modified Labeling Theory (Link et al., 1989) to assess the effects of
stigma associated with HIV/AIDS and cancer on self-esteem. Based on information from
previous studies and focus groups, the final instrument yielded 24 items measuring four
dimensions of perceived stigma: social rejection, internalized shame, social isolation, and
financial insecurity (Fife & Wright, 2001). Examples of instrument items are: “I have
been treated with less respect than usual by others (judgment)”; I feel others avoid me
because of my illness (rejection)”; and “I feel others think I am to blame for my illness
(blame).” The Cronbach’s alphas ranged from .85 to .90 (Fife & Wright, 2000). Seven of
the 24 items representing rejection, judgment, blame and shame dimensions were adapted
for the LuCaSS.
HIV Stigma Scale. The HIV Stigma Scale was originally developed by Sowell et
al. (1997), measures how often individuals have thoughts and feelings of being
stigmatized or feel threatened because of their illness. The greatest contribution of this
scale is that it recognizes that stigma is not a one-dimensional occurrence (Emlet, 2005).
The 13-item instrument utilizes a 4-point Likert type scale ranging from 1 to 4 (1-not at
all, 2-rarely, 3-sometimes, and 4-often). Examples of survey items: “I felt ashamed of my
illness (shame);” “I avoided getting treatment because someone might find out about my
illness (shame);” and “People who know I am HIV (lung cancer) positive treat me with
kid gloves (rejection).” Cronbach’s alpha was .83. Three of the 13 items representing
rejection and shame were adapted for the LuCaSS.
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Modification of these items was necessary to frame them in the context of lung
cancer. For example, “I avoided getting treatment because someone might find out about
my HIV” was modified to, “I avoided getting treatment because someone might find out
about my lung cancer.”
Evaluating the Psychometric Properties of the LuCaSS
Design and Procedure.
A convenience sample of lung cancer patients (N = 104) were invited to complete
a cross-sectional 15-item questionnaire, the Lung Cancer Stigma Survey (LuCaSS), and
they each received a $10 gift card. A total of 125 patients were approached to participate
between July and August 2014 (participation rate = 83.2%). Of these participants,
twenty-one (16.8%) declined due to fatigue or poor health. The university’s medical
institutional review board approved the study materials and procedures. With approval
from clinic physicians, patients were pre-screened by diagnosis before approached by
research staff. There were two methods for administering the survey: 1) REDcap
(Research Electronic Data Capture) electronic data capture tool; or 2) paper/pencil for
participants who preferred this method. REDcap is a secure web-based application for
building and managing online surveys and databases that is hosted by the university and
facilitated by the researcher. All participants chose the REDcap electronic version as the
preferred method of participation in this study. Confidentiality was maintained by
conducting all interviews in the clinic patient rooms where each question was read aloud
to the patient by the research staff.
Sample Recruitment.
The sample was recruited from a medical/surgical thoracic oncology clinic at an
urban academic tertiary care medical center. The study aims were explained to the
medical/surgical thoracic oncology physicians during tumor conference prior to
recruitment. Permission to recruit participants was obtained and patients were prescreened to determine study eligibility: confirmed non-small cell lung cancer (NSCLC)
or small cell lung cancer (SCLC) diagnosis, 18 years and older, and able to read and
understand English.
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Instrument.
An eight-member panel of five lung cancer survivors and three healthcare
professionals with degrees in sociology and psychology disciplines with stigma expertise
agreed to serve as reviewers to determine content validity. Based on procedures
recommended by Streiner and Norman (2008), content experts were asked to assess the
degree to which each of the 65-items from the three pre-existing instruments related to
the concept, clarity, and relevance of stigma in people diagnosed with lung cancer. Of the
65 items reviewed, 45 items were discarded based on a lack of relevance to lung cancer
patients. Of the twenty remaining items, five were discarded due to redundancy. The final
lung cancer stigma survey (LuCaSS) included 15 items (see Table 3.1), each scored on a
4-point Likert scale ranging from “1” (strongly disagree) to “4” (strongly agree). The
response options were arranged so that higher scores indicated greater perceived stigma.
Data Analysis.
To determine summary scores from responses, descriptive statistics (means and
standard deviations or frequency distributions) were calculated for all variables. Internal
consistency of the total scale and the subscales was determined by estimating Cronbach’s
alpha. Pearson’s correlation coefficients were used to estimate the associations among the
LuCaSS subscales. To assess the size and adequacy of partial correlations among
variables, the Kaiser-Meyer-Olkin Measures of Sampling Adequacy (MSA) was applied
to determine whether the associations were sufficient for factorability. MSA scores
greater than 0.60 are deemed sufficient for factorability (Kaiser, 1981), and the MSA
score for this study was 0.86 (p< .001). The sample was found to be favorable for
factorability adequacy using both the Kaiser-Meyer-Olkin Measures of Sampling
Adequacy (MSA) (Kaiser, 1981) and the Bartlett Sphericity Test (Dziuban & Shirkey,
1974).
Principle components analysis was done to assess the dimensionality and
construct validity of the 15-item LuCaSS. The number of subscales was indicated by the
relative size of eigenvalues, as displayed in the corresponding scree plot. A factor-loading
cutoff of .5 was used to gauge which items loaded on which factors. The varimax rotation
was specified for maximum subscale separation. All data analysis was done using SPSS
22.0 (SPSS Inc.)
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Results
Sample Characteristics
The sample comprised 104 patients with lung cancer (all stages and types)
between the ages of 18 and 85 (see Table 3.2). The average age was 61.9 years (SD =9.2).
About half of the participants were male (52.0%) and the majority was Caucasian
(85.6%). Almost sixty percent had graduated from high school and equal percentages
were retired or unemployed/disabled (41.3%). More than three-fifths of participants were
former smokers (63.0%) and 21.2% were current smokers.
Internal Consistency Reliability
The Cronbach’s alpha for the total 15-item Lung Cancer Stigma Scale (LuCaSS)
was 0.89. The Cronbach’s alpha calculated for each of the three subscales also provided
evidence of internal consistency reliability (See Table 3.3). The alphas for the three
subscales ranged from 0.71 to 0.87. Table 3.4 displays the correlations among the
LuCaSS subscales and Cronbach’s alphas. There were eight items in the
judgment/rejection subscale (Cronbach’s alpha = 0.87); three items in the blame/guilt
subscale (Cronbach’s alpha = 0.74); and four items in the shame subscale, (Cronbach’s
alpha = 0.71). These subscales indicated a positive correlation with each other and with
the total score. The strongest correlation was between the total score and the
judgment/rejection subscale.
Construct Validity of the Lung Cancer Stigma Scale (LuCaSS)
Construct validity was evaluated using principle components analysis to
determine the underlying structure of the LuCaSS (See Table 3.3). Principle components
analysis with varimax rotation produced three components with eigenvalues greater than
1, explaining 40.8%, 8.9%, and 8.7% of the variance, respectively. The three components
explained a total 58.5% of the variability among items in the LuCaSS. A 4-point Likerttype scale (strongly disagree, disagree, agree, strongly agree) was used with a score of
four indicating the strongest sense of stigma; all of the items had the same polarity so no
reverse coding was necessary.
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Factor 1. Rejection and judgment subscale
The first subscale consisted of eight items with loadings ranging from 0.52 to
0.78. Seven items had loadings greater than 0.6 on this component. One of these seven
loaded moderately (0.52) on another subscale (i.e., blame/guilt) but was included here
due to higher (0.64) loading on this subscale. One other item loaded on this component]
with a moderate loading of 0.53. These items took the form of rejection and judgment
related to the patient’s personal sense of stigma (Table 3.4).
Factor 2. Blame and guilt subscale
There were three items that loaded on the second component, with loadings
ranging from 0.62 to .081. This factor captured the constructs of blame and guilt
identified from the lung cancer stigma literature and consistent with the blame/guilt
subscale adapted from the HIV/AIDS scale.
Factor 3. Shame subscale
Four items loaded on the third component, with loadings ranging from 0.57 to
0.77; these items captured the construct of shame associated with lung cancer.
Discussion
The final 15-item instrument is representative of a persons’ internalized
experience with feeling stigmatized, with three subscales including social
rejections/judgments, blame/guilt, and shame. The overall Cronbach’s alpha for the
LuCaSS was 0.89, reflecting that the instrument has strong internal consistency reliability
in measuring lung cancer stigma. The principle components analysis determined there
was three subscales that together measured stigma among lung cancer patients. The three
subscales that emerged in the analysis are consistent with constructs identified in studies
of other stigma-associated diseases (Berger et al., 2001; Else-Quest, et al., 2009; Carlson,
et al. 2005; Cataldo, et al., 2011). The 15-item LuCaSS instrument measures internalized
stigma including constructs of social rejections/judgment, blame/guilt, and shame.
Lung cancer patients are at high risk for psychological distress. Feelings of
rejection/judgment, blame/guilt and shame have been identified in lung cancer and they
can create psychological distress that can manifest as a result of being stigmatized. In
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addition, persons who are stigmatized experience depression, anxiety, lack of social
support and a decrease in quality of life that contribute to low self esteem and social
constraints (Else-Quest, et al., 2009; Carlson, et al. 2005; Chapple, et al., 2004; Carmack
et al., 2008; Gonzalez and Jacobsen, 2010; Cataldo, et al., 2011; Johnson, et al., 2014;
Greene and Banerjee, 2006). Hence, understanding the salient constructs that are
associated with stigma among lung cancer patients can provide guidance in preventing or
reducing stigma. For example, noting that a lung cancer patient scores high on feelings of
judgment or rejection provides an opportunity to acknowledge, empathize and offer
support to the patient.
Limitations of this study include convenience sampling reducing generalizability
to the broader lung cancer population. The small sample size consisted of mostly
Caucasian participants from one clinical setting and lacked ethnic and cultural diversity.
Further studies would benefit from a larger, more diverse sample. Given the lack of
stigma measures for lung cancer, it is important to further develop and test brief measures
that could be used by both researchers and clinicians to appropriately assess the stigma
experience. Based on the findings reported here, the LuCaSS is a reliable and valid
measure of lung cancer stigma and may be useful in identifying individuals who feel
stigmatized and could benefit from tailored interventions.
Stigma is an obstacle to prevention, treatment, and access to healthcare among
patients with HIV/AIDS, mental health, and cancer in general (Fife & Wright, 2000;
Chapple, et al., 2004; Sarna, et al., 2005; Schmidt, Else-Quest, et al., 2006; Else-Quest, et
al., 2009; and Unger, 2006). Although there have been several measures of stigma
developed and tested with HIV/AIDS patients as well as cancer in general, only two other
measures have specifically focused on lung cancer stigma (Fortenberry, et al., 2002;
Brown, et al., 2003; Kang, et al., 2006; Buseh, et al., 2006; Berger, et al., 2001; Emlet,
2005; Mak, Cheung, et. al. 2007). First, Hamann et al. (2014) used qualitative methods to
identify stigma-related themes during semi-structured interviews with lung cancer
patients. To date, however, there is not a published scale based on this work. Second,
Cataldo’s 31-item lung cancer stigma scale (CLCSS) was adapted from the Berger et al.
(2001) HIV measure and was found to be a reliable (coefficient alpha .96) and valid
measure of stigma. The CLCSS has four subscales: stigma and shame; social isolation,

40

discrimination, and smoking ranging from 0.75 to 0.96 (Catlado, et al., 2011). The
CLCSS is based on only one HIV stigma scale. In contrast, the LuCaSS includes items
from three different HIV stigma scales (see Table 3.1). Each of the three HIV scales was
representative of the multi-dimensional aspects of perceived stigma, The HIV Stigma
Scale (Berger, et. al. 2001); Social Impact Scale (Fife & Wright, 2000), and HIV Stigma
Scale (Emlet, 2005; Sowell et al., 1997), provided additional insights into the three
LuCaSS constructs of stigma. For example, the Social Impact Scale not only includes
social isolation, but also social rejection and internalized shame (Fife & Wright, 2000).
This instrument was unique in that it was tested among HIV and cancer patients.
Incorporating constructs from three different measures may have further captured the
LuCaSS’ dimensionality of stigma while reducing the number of items necessary for
patients to answer.
Future studies are needed to establish the criterion related validity of the LuCaSS.
For example, the LuCaSS could be compared with other measures of stigma in lung
cancer patients (i.e., Cataldo et al., [2011] lung cancer stigma scale). In addition, because
lung cancer stigma is closely related to smoking stigma, future studies could use the
LuCaSS to examine stigma experiences among patients living in areas with and without
smoke-free policies.
The LuCaSS could be used in lung cancer diagnosis and treatment settings to
identity potential patients who feel stigmatized to promote greater sensitivity from
healthcare providers and family/support persons. Insensitive comments made by
healthcare providers and loved ones may be a result of not knowing what to say, a
reflection of their own fears about developing lung cancer, or lack of knowledge about
the existence or impact of stigma. Comments may be made innocently without thinking
about the impact on the patient feeling stigmatized. For example, healthcare providers
and caregivers could be assessed for blame and anger toward lung cancer patients,
particularly if the patient continues to smoke.. Sensitivity training with healthcare
providers and caregivers may enhance the understanding of how negative and insensitive
comments are linked to emotions and impact the ability to cope. Cancer treatment is
challenging enough without adding hurt feelings or additional stress from insensitive
comments. Healthcare providers and family members who recognize the potential for
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stigma may have a greater ability to empathize with, advocate for, and provide
unconditional support to the lung cancer patient.

Copyright © Lisa Maggio 2015
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Table 3.1. Description of measures used in the development of LuCaSS
Author (Year);
Instrument (s)

Constructs
measured

# of Items;
Response
Scale

LuCaSS
items used
from each
scale

Reliability
coefficient
alpha

Model or
theory

Berger et.al.

Personalized
Stigma,
Disclosure,
Negative self
image, Public
Attitude

40 –item

5

.96

Model of
Perceived
Stigma in
People with
HIV

Social Rejection
& Financial
insecurity,
Internalized
Shame & Social
Isolation

12-items

Distancing

13-item

(2001) HIV
Stigma Scale

Fife & Wright
(2000). Social
Impact Scale

Emlet, (2005);
Sowell, (1997)
HIV Stigma
Scale

4 pt Likert

(Berger,
2001)
.85-.90

Modified
Labeling
Theory (Link
et al. 1989)

3

.83

Goffman
(1963)
Stigma
Theory

12-items
4-pt Likert

Blaming
Discrimination

7

4-pt Likert
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Table 3.2. Sample Characteristics
Characteristic

n

%

Sex
Female
Male
Ethnicity
White
Non-white
Education
High school graduate or less
Some college or greater
Marital Status
Married/Cohabitating
Widowed/ Divorced/ Separated
Never married
Employment
Employed/Homemaker
Retired
Unemployed/disabled
Annual income
< $30,000
$31,000 to $59,999
>$60,000
Preferred not to answer
Insurance type
Private
Medicare/Medicaid
Smoking Status
Never
Former
Current
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50
54

48.1
51.9

89
15

85.6
14.4

62
42

59.6
40.4

59
33
12

56.7
31.7
11.5

18
43
43

17.3
41.3
41.3

37
16
22
29

35.6
15.4
21.2
27.9

59
45

56.7
43.3

12
70
22

11.5
67.3
21.2

Table 3.3. Factor Loadings of the Lung Cancer Stigma Scale (LuCaSS) Items
Statement

Subscale

Component
1

2

3

I have been hurt by how people reacted to
learning I have lung cancer 1

Rejection

0.787

---

---

I feel others avoid me because of my lung
cancer 2

Rejection

0.773

---

---

People judge me for my type of cancer 1

Judgment

0.666

---

---

People’s attitude about lung cancer make
me feel worse about myself 1

Rejection

0.663

---

---

I worry that people will judge me when
they learn I have lung cancer 1

Judgment

0.641

0.538

---

I feel I have been treated with less respect
than usual by others 2

Judgment

0.618

---

---

I feel set apart from others who are well 2

Rejection

0.611

---

---

People who know I have lung cancer treat
me with “kid gloves” 3

Rejection

0.527

---

---

I feel I am at least partially to blame for my
lung cancer 2

Blame

---

0.812

---

I feel others think I am to blame for my
lung cancer 2

Blame

---

0.764

---

I feel guilty because I have lung cancer 1

Guilt

---

0.627

---

I do not think I can be open with others
about my lung cancer 2

Shame

---

---

0.774

I feel I need to keep my lung cancer a
secret 2

Shame

---

---

0.691

I feel/felt ashamed of my lung cancer 3

Shame

---

---

0.679

I avoided getting treatment because
someone might find out about my lung
cancer 3

Shame

---

---

0.571

Sources: 1Berger, et. al. 2001; 2Fife & Wright, 2000; 3Emlet, 2005;Sowell et al., 1997.
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Table 3.4. Correlations and Cronbach’s Alphas for the Lung Cancer Stigma Scale
(LuCaSS) and Subscales
Scale/Subscale

Number
of items

Cronbach’s
alpha

Mean
(SD)

Pearson’s product moment
correlations
Rejection/
Judgment

LuCaSS Total

Blame/
Guilt

Shame

15

0.89

26.4
(6.9)

0.92

0.78

0.74

Rejection/Judgment

8

0.87

14.0
(4.0)

1.00

0.57

0.54

Blame/Guilt

3

0.74

6.2 (2.1)

1.00

0.44

Shame

4

0.71

6.2 (1.9)

Note. All correlations p<. 001

46

1.00

CHAPTER FOUR
Lung Cancer Stigma, Social Support, and Psychosocial Distress
Abstract
Background: Lung cancer patients experience more psychosocial distress than those
with any other type of cancer. Because lung cancer is closely associated with smoking,
society often views the disease as self-inflicted contributing to the “blame the victim”
mentality and the stigma and prejudice often experienced by lung cancer patients.
Blaming patients who contract lung cancer may further influence our interactions with all
lung cancer patients, regardless of their smoking status, denying them the social support
routinely provided to those with other cancer diagnoses.
Purpose: The purpose of this study was to investigate lung cancer stigma, social support,
and psychosocial distress using an adapted Model of Stigma-Induced Identity Threat. The
specific aims were to: 1) explore the relationships among social constraints, self-esteem,
smoking and stigma; 2) determine the relationships of stigma with anxiety and
depression, using smoking and socioeconomic status (SES) as covariates; and 3)
determine if social support mediates the relationships between stigma and psychosocial
distress (as measured by depression and anxiety). It was hypothesized that there would be
a relationship among social constraints, self-esteem, smoking, and lung cancer stigma,
and that social support would mediate the relationships between stigma and psychosocial
distress.
Methods: A cross-sectional study with a convenience sample of 104 patients between the
ages of 18-85 diagnosed with lung cancer. Surveys were administered to lung cancer
patients recruited from an NCI-designated lung cancer clinic using secure online data
collection. Data collected included demographics (age, sex, education, employment,
income, insurance), social constraints, self-esteem, smoking, lung cancer stigma, social
support, depression and anxiety.
Results: Social constraints, self-esteem, and smoking status each significantly
contributed to the prediction of stigma controlling for SES. Social constraints contributed
23%, self-esteem contributed 34%, and smoking status contributed 26% in the final
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stigma model (adjusted R2=. 25, F=4.20, p=<. 0001). In the model without covariates,
stigma was associated with depression (p=. 004) and anxiety (p=. 039). When controlling
for covariates (SES and smoking), however, there was no longer a significant association
between stigma and depression (p=. 229) or stigma and anxiety (p=. 128). Social support
was a strong mediator for the relationship between stigma and depression but was not a
mediator for anxiety.
Discussion: There was a relationship among social constraints, self-esteem, smoking, and
lung cancer stigma. Social support was a strong mediator for predicting the effects of
stigma on depression but not anxiety.
Conclusion: A lung cancer diagnosis can be associated with increased psychological
distress and stigma. Lung cancer patients with greater social constraints and lower selfesteem and who were smokers scored higher on stigma. It will be essential for healthcare
providers to enhance social support for lung cancer patients to mitigate potential stigma
and psychosocial distress. Integrating stigma tools (i.e. LuCaSS) in practice settings will
assist with determining potential stigma related distress among lung cancer patients and
future studies are required to further examine the role of social support in the experience
of stigma and psychosocial distress in lung cancer patients. Such studies can contribute to
minimizing stigma induced identity threat among lung cancer patients.
Introduction
A lung cancer diagnosis means poor survival rates (SEER, 2014), very few
survivors or advocates (NCI, 2012), and limited research funding for awareness,
prevention and treatment (Knapp-Oliver, et al., 2012, NCI, 2012). Because lung cancer is
primarily caused by smoking, society often views the disease as self-inflicted. This view
contributes to the “blame the victim” mentality (Alamar & Glantz, 2006; Gilpin, Lee,
Pierce, 2004; Fichtenberg & Glantz, 2002) and the stigma and prejudice often
experienced by lung cancer patients. Stigmatizing patients who contract lung cancer
(Chappel et al., 2004; Stuber, et al., 2008) may deny them the social support routinely
provided to those with other cancer diagnoses (Raleigh, 2008; Cataldo et al., 2011).

48

Background
Smoking Stigma.
Smoke-free policy initiatives and antismoking campaigns are essential to reducing
the harm from exposure to first and secondhand smoke. However, they may have
unintended consequences resulting in the undesirable reputation and stereotyping of
smoking and smokers (Bell, McCullough, et al., 2010; Bell, Salmon, et al., 2010;Stuber,
et al., 2008; McCool, 2013). As a result, smokers report feelings of shame, described as a
dejected emotional state, placing their self-worth under attack and criticizing “the self”
for failing to live up to the ideals of society (Stuber, et al., 2008; Ritchie, et al., 2010).
Negative feelings about oneself can lead to poor self-esteem and self-concept, threatening
a persons’ social identity and leading to psychosocial distress (Major and O’Brien, 2005).
The growing negative perception of smoking may inadvertently result in stigma against
lung cancer patients (Chapple et al., 2004; Bayer, 2008; Stuber, et al., 2008; Burris,
2008).
Stigma and Social Identity
Stigma is defined as an attribute, behavior, or reputation which is socially
discrediting in a particular way that may cause an individual to be perceived by others in
an undesirable, rejected stereotype rather than in an accepted, normal one (Goffman,
1963). Stigma occurs because of the human need to belong to a group and belonging to a
group is necessary in order to establish a social identity (Tajfel and Turner, 2004; Turner,
1979). Social identity is defined by social and physical characteristics that differentiate us
such as race, ethnicity, religion, occupation, and behaviors (Turner, 1979). Social identity
also affects our self-esteem and our connections or sense of membership with other
people (Tajfel and Turner, 2004). We are motivated to protect our social identity from
anything that causes harm or is devaluing in order to maintain our self-esteem and selfconcept (Steele and Aronson, 1995). Threats to our social identity can lead to
psychosocial distress.
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Psychosocial effects of lung cancer stigma.
Lung cancer patients experience more stigma and psychosocial distress than those
with any other type of cancer (Else-Quest, et al., 2009; Carlson et al., 2005; Chapple e al.,
2004). Psychosocial distress factors such as blame, depression, anxiety and poor quality
of life have been positively correlated with lung cancer stigma (LoConte, Murdoch, 2008;
Gonzalez and Jacobsen, 2010; Johnson, et al., 2014) and reflect feelings of
discrimination, shame, guilt, and social isolation (Alamar & Glantz, 2006; Gilpin, Lee,
Pierce, 2004; Fichtenberg & Glantz, 2002). Lung cancer stigma has also been linked to
lack of empathy in interactions with lung cancer patients (Morse, et al., 2008) and delay
in seeking medical help (Carter-Harris et al., 2014: Tod and Joanne, 2010). This occurs
even though many patients experience symptoms prior to diagnosis (Corner, et al., 2005)
but fear judgment from family and healthcare providers (Carter-Harris, et al., 2014;
Stuber and Galea, 2009).
Social Constraints and Psychosocial Distress.
In addition to experiencing blame and low self-esteem (Else-Quest et al., 2009),
patients with lung cancer also report significant social constraints (Badr & Carmack,
2006; Bayer and Stuber, 2006). Social constraints are barriers that prevent an individual
from expressing thoughts and feelings associated with a traumatic event due to negative
reactions from others. Patients who experience a traumatic event, such as a cancer
diagnosis, need to process the trauma to validate, appraise and find meaning necessary
for successful psychological adjustments (Lepore & Helgeson, 1998; Cordova et al.,
2001). Minimizing social constraints by supporting the expression of thoughts and
feelings may improve psychological adjustment and coping with psychosocial distress.
Social Support.
A main coping strategy necessary for ameliorating psychosocial distress is social
support (Berger, Wagner, Baker, 2005; Brown, 2001; Crocker, Major, & Steele, Whereas
unaddressed psychosocial distress can threaten ones’ self-esteem and social identity,
social support can foster a person’s self-concept and social identity (Major and O’Brien,
2005). A cancer survivor’s ability to cope with the distress of the disease involves the
“mutual influence” of their social network (significant others, family, friends) as a means
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of cognitively and behaviorally addressing the stressors of the disease (Lepore &
Revenson, 2007). Hence, understanding the role of social support in limiting the effects
of psychosocial distress is essential in addressing lung cancer stigma.
Conceptual Framework
Based on the conceptual model of Stigma Induced Identity Threat (Major and
O’Brien, 2005), having a “consensually devalued social identity (stigma)” increases the
likelihood that an individual will experience potentially stressful (identity threatening)
situations (Major and O’Brien, p. 398). Three factors influence identity threat and the
significance of an individual’s appraisal of those factors: collective representations,
situational cues, and personal characteristics (see Figure 4.1).
Collective representations are based on previous experiences and awareness of
cultural norms that enable stigmatized groups to incorporate shared understandings of the
dominant view of their position in society (Crocker, 1999; Crocker et. al., 1998; Steel,
1997). Situational cues and personal characteristics build on collective representations
by reinforcing a lack of value, discrimination or negative stereotype. For example, antismoking media messages may reinforce negative stereotypes of one’s group behavior
(smoking) and the awareness that an evaluator (i.e., society, healthcare provider, patient
support) is prejudice against one’s group (lung cancer patient). The Model of Stigmainduced Identity Threat has been adapted to guide the study reported here to focus solely
on the personal characteristics of stigma. Personal characteristics for this study included
demographic factors such as age, sex, education and employment; social constraints, selfesteem, and smoking (Major and O’Brien, 2005).
The Model of Stigma-induced Identity Threat defines how having a stigmatized
identity can lead to stress and stress-related health outcomes (Major and O’Brien, 2005).
Threat is a situation that communicates the possibility of harm and having a stigmatized
identity increases the individual’s exposure to identity –linked stressors. Stigma-induced
identity threat results from discrimination or other identity-related threatening situations
leading to psychological, social and physical outcomes such as stress, anxiety, and
depression (Major and O’Brien, 2005; Steele and Aronson, 1995; Salvatore, and Shelton,
2007). Identity threat occurs when an individual appraises demands (i.e., collective
responses, situational cues, personal characteristics) imposed by a stigma-relevant
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stressor as potentially harmful to their social identity and exceeds resources available to
cope with those demands (Major and O’Brien, 2005). According to the model, volitional
responses, such as seeking social support, influence our ability to cope by way of
conscious cognitive processes to control emotion, perception, physical and behavioral
responses to stressful situations or events.
The purpose of this study was to determine the relationship among personal
characteristics and lung cancer stigma, and the effects of stigma on psychosocial distress
(i.e., anxiety and depression) guided by an adapted Model of Stigma-Induced Identity
Threat. The specific aims were to: 1) explore the relationships among social constraints,
self-esteem, smoking and stigma; 2) determine the relationships of stigma with anxiety
and depression, controlling for smoking and socioeconomic status (SES); and 3)
determine if social support mediates the relationships between stigma and psychosocial
distress. It was hypothesized that there would be a relationship among social constraints,
self-esteem, smoking, and lung cancer stigma. It was also hypothesized that social
support would mediate the relationships between stigma and psychosocial distress (i.e.,
depression and anxiety).
Methods
Design and Sample
This cross-sectional, descriptive study involved survey administration with a
convenience sample of patients with lung cancer at the University of Kentucky
Multidisciplinary Lung Cancer Clinic (UKMLCC) through the NCI-designated Markey
Cancer Center. The study population included patients between the ages of 18 to 85
years of age and diagnosed with any stage non-small cell lung cancer (NSCLC) or small
cell lung cancer (SCLC) within the past five years. Participants were required to be able
to read and speak English and provide written documentation of consent. Approval was
obtained from the medical Institutional Review Board. A total of 125 lung cancer patients
were invited to participate; twenty-one (16.8%) declined to participate due to fatigue or
poor health. The final sample comprised 104 patients.
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Procedures
Lung cancer patients visiting the UKMLCC clinic were pre-identified and
screened according to the inclusion/exclusion criteria using Sunrise Clinical Manager, the
electronic medical record. A total of 125 patients were approached to participate between
July and August 2014. Of these participants, twenty-one (16.8%) declined due to fatigue
or poor health. A total of 104 patients were consented to take part in the study
(participation rate = 83.2%). The university’s medical institutional review board
approved the study materials and procedures. With approval from clinic physicians,
patients were pre-screened by diagnosis before approached by research staff. The survey
was administered using REDcap (Research Electronic Data Capture) electronic data
capture (Paul et al., 2009), a secure web-based application for building and managing
online surveys and databases that is hosted by the university and facilitated by the
researcher. Confidentiality was maintained by conducting all interviews in the clinic
patient rooms where each question was read aloud to the patient by the research staff.
Participants received a $10 gift card and a lung cancer awareness pin after completing the
survey.
Measures
Lung Cancer Stigma
The identity threat variable in the adapted Model of Stigma-induced Identity
Threat (Major and O’Brien, 2005) was defined as lung cancer stigma and measured using
the 15-item, self-report Lung Cancer Stigma Scale (LuCaSS), an investigator-developed
survey that adapted items from three existing measures of HIV stigma (Fife & Wright,
2000; Berger, et al., 2001; Emlet, 2005; Sowell et al., 1997). Items are rated on a 4-point
Likert scale ranging from (1) ‘strongly disagree’ to (4) ‘strongly agree’. Items are
summed to generate a total score ranging from 15 to 60 with higher total scores
indicating greater perceived stigma. Subscales include judgment/rejection, blame/guilt,
and shame. For example: “I avoided getting treatment because someone might find out
about my lung cancer (judgment/rejection);” “I feel I need to keep my lung cancer a
secret (shame);” “I have been hurt by how people reacted to learning I have lung cancer
(blame/guilt).” The Cronbach’s alpha for the total LuCaSS in this sample was 0.89.
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Psychosocial Distress
Depression and anxiety were measured using the 15-item PROMIS Depression
and Anxiety Scale (DeWalt, et al., 2007; Cella, et al., 2007). The PROMIS initiative, part
of the National Institutes of Health, developed, validated, and standardized item banks to
measure patient reported outcomes pertinent across common medical conditions (Fries et
al., 2005; Kelly, et al., 2010). These instruments measure frequencies of symptoms
reflecting negative affect (depression scale) and autonomic arousal and threat (anxiety
scale) in the past month.
The depression scale consists of eight items and the anxiety scale consists of
seven items with strong psychometric properties. Items are rated on a 5-point Likert scale
ranging from 1 (never) to 5 (always) and summed to generate a total score ranging from
8-40 for depression and 7 to 35 for anxiety. Higher scores indicate greater depression and
anxiety. The Cronbach’s alpha for depression was 0.91 and the Cronbach’s alpha for
anxiety was 0.93. A sample item for depression is: “In the past month I felt worthless;”
for anxiety “In the past month I felt worried.”
Personal Characteristics
According to the Model of Stigma-Induced Identity Threat (Major and O’Brien,
2005), personal characteristics influence how situations are perceived and appraised.
Personal characteristics included in the model adapted for the study reported here were
social constraints, self-esteem, smoking, and demographics (see Figure 4.1).
The Social Constraints Scale (SCS) (Lepore, 1997) measured the social
conditions or environments that cause trauma by discouraging expression of emotions.
Participants were asked to respond to the 15-item SCS to assess social constraints related
to disclosure about cancer. Responses for each item were rated on a 4-point Likert scale
ranging from (1) ‘never’ to (4) ‘often’. Total scores range from 15 to 60 with higher
scores indicating greater social constraints. Sample items are: How often in the past
month did your (family/friends) “change the subject when you tried to discuss your
experience with cancer,” “avoid you,” and “give you the idea they didn’t want to hear
about your experiences with cancer.” Cronbach’s alpha for the SCS for this sample was
0.83.
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Rosenberg Self Esteem is a widely used self-report instrument for evaluating
individual self-esteem and is a measure of global self-worth for both positive and
negative feelings about the self (Rosenberg, 1979). The construct was measured using the
10-item uni-dimensional scale. Responses are rated on a 4-point Likert scale ranging
from (1) ‘strongly agree’ to (4) ‘strongly disagree.’ A total score is calculated as the
average of the 10-items with ranges from 10 to 40. Sample items are: “I take a positive
attitude toward myself” and “I feel I do not have much to be proud of.” Being stigmatized
may contribute to a lower self-esteem score and identity threat. Cronbach’s alpha was
0.84 for this sample.
Smoking items were adapted from the Global Adult Tobacco Survey
Collaborative Group (GATS, 2011). This survey is considered standard for monitoring a
variety of tobacco related questions to assess current, former and never tobacco use
(GATS, 2011). A total of 8 questions measuring smoking history such as age of tobacco
initiation, advice to quit, and quit attempts were included. Current smoking is defined as
the percentage of respondents who had smoked tobacco in the past 30 days; former
smoker is defined as the percentage of participants who had ever smoked but who were
currently not smoking; never smokers are those who had never smoked and not currently
smoking. For mediation analysis, smoking status was categorized into ‘current’ versus
‘former/never’ smoker categories.
Demographic variables. Sex (male/female), age of participants (in years), marital
status (married/cohabitating vs. widowed/divorced/separated vs. never married), ethnicity
[(white vs. non-white (African American, Asian, Hispanic)], educational level [(high
school graduate or less, some college or greater (less than 1 year, college degree,
Bachelors/Masters/Doctoral degree)], annual income level ($30,000 or less, $31,00059,999, $60,000 or greater, prefer not to answer), health insurance (private vs.
Medicare/Medicaid) were assessed.
Social Support
Social support was selected as the volitional response variable, measured by the
Duke—UNC Functional Social Support Questionnaire (DUKE SSQ), an 8-item selfreport scale designed to measure satisfaction with available social support (Broadhead et
al., 1988). Items were rated on a 5-point Likert scale ranging from 1 (much less than I
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would like) to 5 (as much as I would like). Items are summed to create a total score
ranging from 8 to 40 with higher total scores indicating greater social support. Sample
items include: ‘People care what happens to me…’ and ‘chances to talk to someone I
trust about my personal and family problems,’ with responses ranging from ’as much as I
would like’ to ‘much less than I would like.’ Cronbach’s alpha for the Duke SSQ in this
sample was 0.83.
Data Analysis
The study variables were summarized using frequencies (for categorical) or
means with standard deviations (for continuous variables). Personal characteristics
including, social constraints, self-esteem, smoking, demographics and lung cancer stigma
(i.e., identity threat), and social support (i.e., volitional responses); and depression and
anxiety were tested for bivariate associations using chi-square analyses for categorical
variables and t-tests for continuous variables. Relationships between the personal
characteristics and outcome variables were determined using the two-sample t-test,
analysis of variance (ANOVA), and the Kruskal-Wallis test. Pearson’s correlations were
used to assess associations between continuous demographic and personal variables and
the main outcome variables. Post hoc analysis was performed when the ANOVA
indicated a significant group effect overall.
To test whether social support mediated the relationship between stigma and
depression/anxiety (see Figure 4.2), multiple regression analysis was used following the
four-step method described by Baron and Kenny (1986). For this study, the four steps to
be satisfied before mediation could take place included ensuring that: 1) the predictor
variable (stigma) was a significant predictor of the mediator variable (social support); 2)
the predictor variable (stigma) was a significant predictor of the outcome variable
(depression); 3) the mediator (social support) was a significant predictor of the outcome
(depression); and 4) when both the mediator (social support) and the predictor (stigma)
were included in the same regression as potential predictors of the outcome (depression),
the latter was no longer significant. The Sobel test was performed to assess the statistical
significance of the indirect effect of the mediator in each of the mediation models (Sobel,
1982).
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The multiple regression standardized beta weights were used to summarize the
direct and indirect effects of the predictor or mediator on the outcome as the direct effect
(i.e., the regressions with just one independent variable) and the indirect effect of stigma
on the outcome when the mediator was included in the regression. Each regression model
contained the following demographic and personal characteristics as control variables:
age, sex, smoking status (current vs. former/never), and employment status
(retired/disabled vs. other). These control variables were chosen because they are the
known demographic and disease-specific indicators that may be most closely aligned
with the outcomes. All analyses were performed using the SPSS Statistics 22.0. An alpha
level of .05 was used throughout the analysis (SPSS, 2009).
Results
Demographic Characteristics
Table 4.1 summarizes the characteristics of the sample. The sex of participants
was approximately equally distributed (48% women). Participants were primarily white
(86%), former smokers (67%), and married (57%), with a mean age of 61.9 (SD = 9.2)
years. Sixty percent had a high school degree or less education. Most participants were
either retired (41%) or unemployed/disabled (41%) and more than half had private
insurance (57%). More than half of participants made less than $60,000/year (51%);
nearly one in three preferred not to disclose annual income (28%).
Scale scores
The average score on the LuCaSS scale was 26.4, (SD= 6.7). The depression
subscale score was 16.3 (SD=6.8); anxiety subscale score was 17.3 (SD=7.0). The social
constraints scale was 22.2 (SD= 6.6); self-esteem scale score was 22.5 (SD=4.9), and the
social support scale was 35.4 (SD=5.7).
Associations of social constraints, self-esteem, and smoking with stigma
Aim 1 was to examine the associations of social constraints, self-esteem and
smoking with stigma (see Table 4.2). Controlling for SES variables, social constraints,
self-esteem, and smoking status each significantly contributed to stigma. Social
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constraints contributed 23%, self-esteem contributed 34%, and smoking status
contributed 26% to stigma in the final model.
Association of stigma with anxiety and depression controlling for SES and smoking
For Aim 2, the relationships of stigma with anxiety and depression were
examined (see Table 4.3). In the model without covariates, stigma was associated with
depression (p=. 004) and anxiety (p=. 039). When controlling for SES and smoking, there
was no longer a significant association between stigma and depression (p=. 229) or
stigma and anxiety (p=. 128).
Test of social support as a mediator of the relationships of stigma with depression
and anxiety
For Aim 3, a mediation analysis was conducted to test whether social support
mediated the relationship of stigma with depression and anxiety (see Table 4.5). Social
support was a strong mediator of the relationship between stigma and depression (Figure
4.2). However, social support was not a mediator of the relationship between stigma and
anxiety, because stigma did not significantly predict anxiety.
Discussion
The first hypothesis was that there would be a relationship among social
constraints, self-esteem, smoking, and lung cancer stigma. Indeed, lung cancer patients
who reported greater social constraints, lower self-esteem, and who were current smokers
scored higher on the stigma measure. Consistent with the literature, lung cancer patients
experiencing stigma may also encounter greater social constraints and lower self-esteem
(Badr, and Taylor, 2006; Else-Quest, et al., 2010; Cataldo, et al., 2011). Further, smokers
experience more stigma than non-smokers (Chapple, et al., 2004; Gulyn & Youssef;
2010; Cataldo, et al., 2011).
Individuals who experience social constraints may avoid talking about cancer in
an attempt to buffer against upsetting “intrusions” such as being blamed for their
smoking behavior. The findings indicated that social constraints were significantly
associated with stigma even after controlling for SES, social constraints, self-esteem, and
smoking. Experiencing social constraints may be associated with stigma by directly
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exposing the stigmatized to environments that limit access to supportive relationships and
resources (Link & Phelan, 2001). However, supportive social networks can provide a
context for cognitive processing of traumatic events utilizing verbal disclosure of
thoughts and feelings, which can improve mental health (Lepore and Helgeson, 1998).
Stigma contributes to low self-esteem, can threaten a person’s identity and varies
as a function of personal characteristics (Crocker, 1999). In one study for example,
pessimistic women who were exposed to persistent sexism experienced more threat
appraisals and lower self-esteem than optimistic women (Kaiser, et al., 2004).
Longitudinal and cross-sectional studies of individuals experiencing stigmatized
identities have shown that stigma precedes reduced self-esteem in people with mental
illness (Verhaeghe, et al., 2008), individuals with HIV (Fife and Wright, 2000), and in
those with lung cancer (Fife and Wright, 2000; Else-Quest, et al., 2010; Cataldo, et al.,
2011).
Lung cancer patients who smoke experience more stigma than non-smokers
(Stuber, et al., 2008). The level of responsibility that a person assigns to their illness (i.e.,
smoking as a cause of lung cancer) determines the degree of perceived stigma (Falk,
2001). Controllable factors such as smoking, elicit greater negative reaction than from
uncontrollable factors (Falk, 2001). Smokers are viewed more negatively and experience
more self-blame than non-smokers (LoConte, Else-Quest, et al., 2008; Gulyn, & Youssef,
2010) due, in part, to the unintended consequences of smoke-free policies and antismoking campaigns (Stuber, et al., 2008; Fichtenberg & Glantz, 2002).
For the second hypothesis, social support mediated the relationship of stigma with
depression. Social support was a strong mediator for predicting the effects of stigma on
depression; when included in the model, social support changed the relationship between
stigma and depression, suggesting that strong social support may decrease the negative
effect of stigma on depression. Therefore, it is possible that in understanding depression
among lung cancer patients, social support may lessen the impact of depression as a
result of their feelings or experiences of being stigmatized. These findings are
preliminary and need to be replicated to better understand the nature of the relationships
between stigma, social support and depression.
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Social support was not a mediator for predicting the effects of stigma on anxiety.
There was not an observed relationship between the independent variable (stigma) and
the dependent variable (anxiety). In the mediation model, the effects of stigma on anxiety
were not significant, and social support was not a mediator of stigma and anxiety. This
finding could be related to the time parameters on the anxiety survey instrument “in the
past month” that may have influenced responses. Also, the data are cross-sectional and
finding a convincing association may be more likely in a longitudinal design. It is
possible that anxiety (feeling fearful, anxious, worried, nervous, uneasy, tense) could
precede or contribute to stigma or perhaps social support is not the best mediator or
volitional response. There may be other positive mediators, such as meditation or specific
complimentary therapies that may impact the effects of stigma on anxiety. Future studies
are needed to further examine the association between stigma and anxiety using robust
data sets and longitudinal design.
Limitations
There are several limitations to this study. First, the non-probability sample did
not fully represent the general lung cancer population. The sample was homogenous with
respect to race and ethnicity, which limits generalizability to the broader lung cancer
population. The sample size was small (n =104), although adequately powered based on
preliminary power analysis calculations (Cohen, 1988). The age of the sample was
slightly younger than the national average (62 years vs. 72 years) (ACS, 2012). There
may have been some bias in that almost all interview responses were given aloud with a
caregiver/family/friend in the room and this may have influenced the truthfulness in
answering questions related to anxiety, social constraints and social support. Finally, lung
cancer awareness has been growing steadily for the last eight years (Norris, 2015), which
may have affected how the population perceives stigma or other variables such as patient
support organizations and advocacy events affecting some of the main outcomes.
Future Research
Future psychometric testing of the LuCaSS is needed with a larger more diverse
population. While the LuCaSS assesses perceived stigma of an individual diagnosed with
lung cancer, studies are needed to examine differences in perceived stigma between
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patient and caregiver. Further, research is needed to evaluate the feasibility and usability
of implementing the LuCaSS as part of the clinical assessment when patients are initially
diagnosed with lung cancer. If stigma can be identified early in the lung cancer diagnosis,
interventions including social support can be developed and tested to minimize identity
threat and psychosocial distress.
Other research implications may include exploring if lung cancer patients from
counties/cities with smoke-free policy experience more stigma than those without a
smoke-free policy. Anti-smoking and dangers of secondhand smoke messages may be
more prevalent in smoke-free areas contributing to the societal view of smokers and lung
cancer stigma. There may be opportunities to explore if interventions aimed at providing
social support through advocacy can impact stigma outcomes.
Experiencing stigma can lead to psychosocial distress. Recognizing distress is one
of the quality measures recommended by the Commission on Cancer (CoC), a program of
the American College of Surgeons (ACoS), that recognizes cancer care programs for
their commitment to providing comprehensive, high quality, and multidisciplinary patient
centered care. The CoC is dedicated to improving survival and quality of life for cancer
patients through standard setting and the monitoring of comprehensive quality care.
Psychosocial Distress Screening (Standard 3.2) is a 2012 Standard and must be phased-in
for 2015 (Commission on Cancer, 2012). All cancer programs will need to demonstrate
that they screen patients diagnosed with cancer for distress. Through the CoC standards,
the LuCaSS may help identify stigma that leads to psychosocial distress and can
negatively impact the wellbeing of the lung cancer patient.
Conclusion
A lung cancer diagnosis can be associated with stigma and increased psychosocial
distress (Else-Quest, et al., 2006; Chapple, et al., 2004; Cataldo, et al., 2011). The
findings of the study reported here are consistent with the Model of Stigma Induced
Identity Threat (Major and O’Brien, 2005) which states that having a stigmatized identity
can be affected by social constrains, lower self-esteem, smoking and can lead to stress
and stress-related health outcomes such as depression and anxiety (Major and O’Brien,
2005). To date, no other studies have applied the Model of Stigma Induced Identity
Threat to lung cancer stigma research or tested whether social support mediated the
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relationship between stigma and depression/anxiety. These findings specifically
emphasize the need for healthcare providers to enhance social support for lung cancer
patients in order to mitigate potential stigma and psychosocial distress. In addition, it is
important to find a way to integrate stigma tools (i.e. LuCaSS) in practice settings when
encountering lung cancer patients to determine potential stigma related distress. Finally,
future studies are required to further examine the role of social support in the experience
of stigma and psychosocial distress in lung cancer patients. Such studies can contribute to
minimizing stigma induced identity threat among lung cancer patients.

Copyright © Lisa Maggio 2015

62

Table 4.1. Sample Characteristics (N=104)
Characteristic

n

%

50
54

48.1
51.9

Ethnicity
White
Non-white

89
15

85.6
14.4

Education
High school or less
Some college or greater

62
42

59.6
40.4

Marital status
Married/Cohabitating
Widowed/Divorced/Separated
Never married

59
33
12

56.7
31.7
11.5

Employment
Employed/Homemaker
Retired
Unemployed/disabled

18
43
43

17.3
41.3
41.3

Annual income
Less than $30,000
$31,000 to $59,000
$60,000 or more
Prefer not to answer

37
16
22
29

35.6
15.4
21.2
27.9

Insurance type
Private
Medicare/Medicaid

59
45

56.7
43.3

Smoking Status
Never
Former
Current

12
70
22

11.5
67.3
21.2

Sex
Female
Male
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Table 4.2. Association of Stigma with Each of Social Constraints, Self-Esteem, and
Smoking, Controlling for SES

Variables

Estimated Beta

t

(p-value)

.23

2.3

(.021)

-.34

-3.3

(.002)

.26

2.8

(.006)

Social Constraints
Self-esteem
Smoking status (former/current vs.
never smoker

Note: Final model controlling for sex, age, marital status, education, employment status, race and
type of insurance.
Adjusted R2 =. 25, F=4.2, df=10, p=<. 0001
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Table 4.3. Association of Stigma with Each of Depression and Anxiety, Unadjusted
for Covariates and Adjusted for SES and Smoking
Variable

Beta

t

(p-value)

Depression

.28

2.94

(.004)

Anxiety

.20

2.09

(.039)

LuCaSS Scale Score (unadjusted)

LuCaSS Scale Score (adjusted for covariates)
Depression

.12

1.21

(.229)

Anxiety

.18

1.53

(.128)

Note: Model for depression and anxiety were adjusted for SES and smoking status.
Adjusted model for depression, adjusted R2 =. 27, F=5.02, p<. 0001); Adjusted model for anxiety,
adjusted R2 =. 05, F=1.53, p=. 149.
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Table 4.4. Means, Standard Deviations and Correlations Among Predictor,
Mediator and Dependent Variables (N = 104)
Variable

Variable type

Correlation (p-value)
Stigma

Social support

Stigma

Predictor

Social Support

Mediator

-.32 (.001)

Depression

Outcome

.28 (.004)

-.37 (<. 001)

Anxiety

Outcome

.20 (.039)

-.26 (.008)
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Depression

.73 (<.001)

Table 4.5. Test of Mediation for the Relationships of Stigma and Social Support as
They Predict Depression and Anxiety (N = 104)*
1. Social Support mediates the effect of Stigma on Depression.
Predictor

Potential
mediator

Outcome

Stigma

Social support

Stigma
Support
Stigma

Support

Std b for
predictor

p-value

-0.31

.003

Depression

0.20

.029

Depression

-0.26

.004

Depression

0.11

.23

Sobel test p-value

.020

2. Social Support does not mediate the effect of Stigma on Anxiety.
Predictor

Potential
mediator

Outcome

Stigma

Social support

Stigma
Support
Stigma

Support

Std b for
predictor

p-value

-0.31

.003

Anxiety

0.18

.086

Anxiety

-0.23

.025

Anxiety

0.13

.25

Sobel test p-value

.070

*Note – Covariates included in each model were: age, sex, employment status and current
smoking status.
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Figure 4.1 An Identity-Threat Model of Stigma in Lung Cancer
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Figure 4.2. Direct and Indirect Effects of Stigma on Depression and Anxiety.
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CHAPTER FIVE
Conclusions
Three papers were presented in this dissertation: 1) “Stigma, Smoking and Lung
Cancer: A Systematic Review of the Literature;” 2) “Lung Cancer Stigma Scale
(LuCaSS): Measuring Perceived Stigma in People with Lung Cancer;” and 3) “Lung
Cancer Stigma, Social Support, and Psychosocial Distress.”
The first paper was a systematic review and the primary aims were to: a) explore
the concepts of health-related stigma; b) describe the current status of lung cancer
research funding and advocacy related to lung cancer stigma; c) explore the relationship
between smoking stigma and lung cancer; and d) provide an overview of the Model of
Stigma-Induced Identity Threat and the psychosocial effects of being stigmatized.
Stigma is a social process resulting in discrediting or devaluation of a person or
group and exists as a means of social control and regulating behavior (Goffman, 1963).
Stigma is most likely to exist among people with diseases linked to controllable causes
such as smoking (Falk, 2001), prompting less empathy and more blame (Chapple, et al.,
2004; Gulyn and Youssef, 2010) compared to other diseases with a less known cause.
Smoking represents the primary cause of lung cancer and is related to growing negative
public perceptions that unintentionally result in stigma against lung cancer patients
(Fichtenberg and Glantz, 2002; Stuber, et al., 2008). As a result, lung cancer patients are
often viewed as responsible for or deserving of their disease regardless of their smoking
status and they may experience higher levels of cancer-related stigma than patients with
other cancers (Stuber, et al., 2008)
The stigma experienced by many lung cancer patients negatively impacts
psychological adjustments and interpersonal communication. The Model of StigmaInduced Identity Threat explains how stigma “threatens a person’s identity,” or their selfconcept and is associated with greater distress, poorer psychological adjustment (Major
and O’Brien, 2005), and limited use of support services (Morse, et al., 2008; CarterHarris et al., 2014). Lung cancer stigma as “identity threat” may have influenced the lag
in appropriate research funding and advocacy related to lung cancer, limiting advances in
better prevention, treatment, and survival (Knapp-Oliver and Moyer 2012). The Model of
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Stigma-Induced Identity Threat was adapted to guide research described in the second
and third papers.
The second paper was a psychometric analysis of the Lung Cancer Stigma Scale
(LuCaSS), developed by the investigator to assess perceived stigma in lung cancer
patients and address the void in brief measures currently available. The purpose of this
study was to describe the development of an investigator-developed instrument, “Lung
Cancer Stigma Scale” (LuCaSS) and evaluate its psychometric properties by: 1)
describing the internal consistency of the LuCaSS; and 2) assessing the construct validity
of the instrument through principle components analysis (PCA).
There is convincing scientific evidence that lung cancer patients experience
stigma and are at high risk for psychosocial distress (Chapple, et al., 2004; Cataldo, et al.,
2011; Else-Quest, et al., 2009). The development of this instrument was adapted from
those known to measure HIV stigma (Berger, et. al. 2001; Fife & Wright, 2000; Emlet,
2005; and Sowell et al., 1997). The LuCaSS was found to be a reliable and valid
instrument measuring lung cancer stigma. Three subscales measuring internalized stigma
were identified: social rejection/judgment, blame/guilt, and shame. Testing instruments
that assess stigma assist in understanding the salient constructs associated with stigma
and are necessary to test interventions that may minimize stigma experienced by lung
cancer patients.
The third paper investigated lung cancer stigma, social support, and psychosocial
distress using the adapted Model of Stigma-Induced Identity Threat. Because lung cancer
is closely associated with smoking, society often blames lung cancer patients (Gulyn and
Youssef, 2010; Ritchie, et al., 2010; Chapple, et al., 2004). This may affect interactions
with all lung cancer patients, regardless of their smoking status, creating psychosocial
distress (Chapple, 2004; Gonzalex and Jacobsen, 2010; Cataldo, et al., 2011; Johnson, et
al., 2014) and denying them the social support routinely provided to those with other
cancer diagnoses (Badr, and Taylor, 2006; Else-Quest, et al., 2009; LoConte, et al.,
2008).
The purpose of this study was to determine the relationship among personal
characteristics and lung cancer stigma, and the effects of stigma on psychosocial distress
(i.e., anxiety and depression) guided by an adapted Model of Stigma-Induced Identity
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Threat. The specific aims were to: 1) explore the relationships among social constraints,
self-esteem, smoking and stigma; 2) determine the relationships of stigma with anxiety
and depression, controlling for smoking and socioeconomic status (SES); and 3)
determine if social support mediates the relationships between stigma and psychosocial
distress. It was hypothesized that there would be a relationship among social constraints,
self-esteem, smoking, and lung cancer stigma. It was also hypothesized that social
support would mediate the relationships between stigma and psychosocial distress (i.e.,
depression and anxiety).
A convenience sample of lung cancer patients (N = 104) were recruited from the
University of Kentucky Multidisciplinary Lung Cancer Clinic (UKMLCC) through the
NCI-designated Markey Cancer Center. Participants were surveyed in a cross-sectional
study to explore the relationship among social constraints, self-esteem, smoking, and lung
cancer stigma. Social support was also investigated as a mediator in the relationships
between stigma and psychosocial distress (depression and anxiety). Lung cancer patients
who reported greater social constraints, lower self-esteem, and who were current smokers
scored higher on the stigma measure. Social support may be a meaningful coping strategy
and was found to be a strong mediator for predicting the effects of stigma on depression
but not anxiety. The findings are consistent with the Model of Stigma Induced Identity
Threat, having a stigmatized identity can lead to stress and stress-related health outcomes
such as depression.
Future Research and Practice Implications
Future studies are needed to advance understanding of lung cancer stigma and the
effects on patients and their caregivers, as well as to develop and test interventions to
minimize stigma in this high-risk population. Although the LuCaSS developed and tested
in this dissertation was found to be a reliable and valid tool, future research is warranted
to compare the LuCaSS with other newly designed measures of lung cancer stigma (i.e.
Cataldo et al., 2011) to establish criterion related validity. Additional psychometric
testing is also needed to test the LuCaSS with a larger more diverse population. The
LuCaSS assesses an individual’s perceived stigma when they are diagnosed with lung
cancer. Differences in perceived stigma between healthcare providers, and caregivers
could also be examined. The LuCaSS could also be evaluated for feasibility and usability
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as part of the clinical assessment when patients are initially diagnosed with lung cancer.
Implementing the LuCaSS to identify perceived stigma could, in part, satisfy the
Commission on Cancer (CoC) psychosocial distress screening standard for quality
measures.
Future research is also needed to explore if lung cancer patients from
counties/cities with smoke-free policy experience more stigma than those without a
smoke-free policy. If this is determined, clinical settings and public health organizations
could partner to develop and test interventions to minimize stigma in these communities.
The findings from this study specifically emphasize the need for healthcare providers to
enhance social support for lung cancer patients to mitigate potential stigma and
psychosocial distress. Further, the impact of advocacy events (e.g., lung cancer
walks/runs) and/or other interventions designed to provide social support could be tested
to examine whether participation in these events might diminish the effects of stigma on
depression in lung cancer patients. In addition, future studies are required to further
examine the role of social support in the experience of stigma and psychosocial distress
in lung cancer patients. Such studies can contribute to minimizing stigma induced
identity threat among lung cancer patients.
Finally, stigma in lung cancer occurs, in part, as an unintended consequence of
smoke-free policies and antismoking campaigns. Some may question if it is ethical to
stigmatize smokers in order to change behavior and social norms associated with
smoking? Although the ethical considerations have been argued (Bayer, 2008; Burris,
2008), the more appropriate question is what can be done to minimize stigma? If the goal
is to decrease the effects of smoking related stigma on lung cancer patients, strategies
learned from other stigmatized health conditions could be developed and tested to reduce
lung cancer stigma (Berger et al., 2005). For example, to lessen the stigma associated
with lung cancer stigma, it is important to cast the disease as treatable. When there is fear
associated with the disease due to limited treatment and survival, there is greater stigma
(Goffman, 1963; Falk, 2001).
Some advances in lung cancer prevention, early detection and treatment are being
made. Early detection and prevention continue to be addressed through tobacco treatment
(Fiore, 2008), smoke- and tobacco-free policy (Callinan, et al. 2014), and early detection
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through low dose CT screening (Wood, et al., 2012). Early detection and screening for
lung cancer may provide the “hope” necessary to identify “at risk” patients and lead to
improved survival rates for lung cancer patients. Other advances in treating lung cancer
that are making a small impact on survival include the identification of actionable
mutations and discoveries of newer targeted therapies (Johnson and Schiller, 2014).
Although there have been some advances in prevention and treatment, the
challenges for lung cancer patients are still enormous. Lung cancer is severely
underfunded in both the public and private sectors. The two main factors contributing to
underfunding lung cancer research are stigma and the dismal 5-year survival rate (KnappOliver and Moyer, 2012), which hasn’t changed in 40 years (13% in the 1970’s versus
17% in 2013) (SEER, 2013). The poor survival rate affects the number of survivors
available to advocate for awareness and adequate funding for better treatments. Unless
these factors are addressed, efforts to improve the lives of lung cancer patients and
impact survival may not be attainable.
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